Matti Uusitupa

Murphy, Rachel A; Tintle, Nathan; Harris, William S; Darvishian, Maryam; Marklund, Matti; Virtanen, Jyrki K; Hantunen, Sari; de Mello, Vanessa D; Tuomilehto, Jaakko; Lindström, Jaana; Bolt, Matthew A; Brouwer, Ingeborg A; Wood, Alexis C; Senn, Mackenzie; Redline, Susan; Tsai, Michael Y; Gudnason, Vilmundur; Eiriksdottir, Gudny; Lindberg, Eva; Shadyab, Aladdin H et al [incl. Uusitupa, Matti]. 2022. Omega-3 and omega-6 polyunsaturated fatty acid biomarkers and sleep: a pooled analysis of cohort studies On behalf of the Fatty Acids and Outcomes Research Consortium (FORCE) American journal of clinical nutrition 115 3: 864-876. 2022

Mägi, Reedik; Hottenga, Jouke- Jan; Grallert, Harald; Perry, John R. B.; Bouatia-Naji, Nabila; Marullo, Letizia; Rybin, Denis; Jansen, Rick; Min, Josine L.; Dimas, Antigone S.; Ulrich, Anna; Zudina, Liudmila; Gådin, Jesper R.; Jiang, Longda; Faggian, Alessia; Bonnefond, Amélie; Fadista, Joao; Stathopoulou, Maria G.; Isaacs, Aaron; Willems, Sara M et al. [incl. Kuusisto, Johanna; Laakso, Markku; La. 2021. Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability Nature communications 12 1: 24. 2021

Chen, J; Spracklen, CN; Marenne, G; Varshney, A; Corbin, LJ; Luan, J; Willems, SM; Wu, Y; Zhang, X; Horikoshi, M; Boutin, TS; Mägi, R; Waage, J; Li-Gao, R; Chan, KHK; Yao, J; Anasanti, MD; Chu, AY; Claringbould, A; Heikkinen, J; et al. [incl. Kuulasmaa, T; Kuusisto, J; Laakso, M; Lakka, T; Uusitupa, M; Vangipurapu, J]. 2021. The trans-ancestral genomic architecture of glycemic traits Nature genetics 53 6: 840-860. 2021

Uudet tutkimusmenetelmät ja yksilöity ravitsemushoito. Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Tyypin 2 diabeteksen ehkäisy. Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Tehohoitopotilaan ravitsemushoito. Ala-Kokko, Tero; Bäcklund, Minna; Schwab, Ursula; Niinikoski, Harri; Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Syömisen säätely. Uusitupa, Matti; Karhunen, Leila / Ravitsemustiede (8. uud. painos). 2021. 2021

Sydän- ja verisuonitautien ehkäisy ja riskitekijöiden lääkkeetön hoito. Schwab, Ursula; Uusitupa, Matti; Niinikoski, Harri / Ravitsemustiede (8. uud. painos). 2021. 2021

Sydämen vajaatoiminta. Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Rintamäki, Reeta; Rautio, Nina; Peltonen, Markku; Jokelainen, Jari; Keinänen-Kiukaanniemi, Sirkka; Oksa, Heikki; Saaristo, Timo; Puolijoki, Hannu; Saltevo, Juha; Tuomilehto, Jaakko; Uusitupa, Matti; Moilanen, Leena. 2021. Long-term outcomes of lifestyle intervention to prevent type 2 diabetes in people at high risk in primary health care Primary care diabetes 15 3: 444-450. 2021

Ravitsemustilan arviointi ja ravinnonsaannin tehostaminen. Uusitupa, Matti; Fogelholm; Schwab, Ursula / Ravitsemustiede (8. uud. painos). 2021. 2021

Ravitsemustiede. Mutanen, Marja; Niinikoski, Harri; Schwab, Ursula; Uusitupa, Matti. 2021 2021

Uusitupa, Matti. 2021. Fruit and Vegetables consumption and Type 2 diabetes prevention The Global Fruit & Veg Newsletter 63: -. 2021

Mustajoki, Pertti; Uusitupa, Matti. 2021. Tyypin 2 diabeteksen Käypä hoito -suosituksessa laihduttaminen jää sivuosaan Duodecim 137 6: 654 - 655. 2021

Lihavuus sairautena. Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Lihavuuden syyt. Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Lihavuuden hoito. Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Lihavuuden ehkäisy. Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Kihti ja nivelreuma. Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Kehon koostumuksen mittaaminen. Fogelholm, Mikael; Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Heikentynyt glukoosinsieto, insuliiniresistenssi ja metabolinen oireyhtymä ja niiden ehkäisy. Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

Diabetes sairautena ja sen ravitsemus- ja muu hoito. Uusitupa, Matti / Ravitsemustiede (8. uud. painos). 2021. 2021

de Mello, Vanessa Derenji; Selander, Tuomas; Lindström, Jaana; Tuomilehto, Jaakko; Uusitupa, Matti; Kaarniranta, Kai. 2021. Serum Levels of Plasmalogens and Fatty Acid Metabolites Associate with Retinal Microangiopathy in Participants from the Finnish Diabetes Prevention Study Nutrients 13 12: 4452. 2021

Lindström, Jaana; Uusitupa, Matti; Eriksson, Johan; Ilanne-Parikka, Pirjo; Keinänen-Kiukaanniemi, Sirkka; Tuomilehto, Jaakko. 2021. Mitä suomalainen tyypin 2 diabeteksen ehkäisytutkimus DPS on opettanut? Duodecim 137 22: 2399-2406. 2021

Uusitupa, Matti; Mustajoki, Pertti; Pietiläinen, Kirsi. 2020. Covid-19-tauti muistuttaa lihavuuden hoidon merkityksestä Lääkärilehti 75 36: 1736. 2020

Uusitupa, Matti; Niskanen, Leo; Laitinen, Tomi. 2020. Divergent pathologies and treatment options for diabetic neuropathies Diabetologia 63: 1947-1948. 2020

Uusitupa, Matti; Schwab, Ursula. 2020. Evolving Nutritional Therapy for Diabetes Mellitus Nutrients 12 2: 423. 2020

Uusitupa, Matti. 2020. Tyypin 2 diabetesepidemia odottaa edelleen ratkaisuja Lääkärilehti 75 12: 740. 2020

Sluggett, JK; Koponen, M; Bell, JS; Taipale, H; Tanskanen, A; Tiihonen, J; Uusitupa, M; Tolppanen, AM; Hartikainen, S. 2020. Metformin and risk of Alzheimer's disease among community-dwelling people with diabetes: a national case-control study Journal of clinical endocrinology and metabolism 105 4: dgz234. 2020

Pfeiffer, AFH; Pedersen, E; Schwab, U; Risérus, U; Aas, AM; Uusitupa, M; Thanopoulou, A; Kendall, C; Sievenpiper, JL; Kahleová, H; Rahélic, D; Salas-Salvadó, J; Gebauer, S; Hermansen, K. 2020. The Effects of Different Quantities and Qualities of Protein Intake in People With Diabetes Mellitus Nutrients 12 2: 365. 2020

Imamura, Fumiaki; Fretts, Amanda M; Marklund, Matti; Ardisson Korat, Andres V; Yang, Wei-Sin; Lankinen, Maria; Qureshi, Waqas; Helmer, Catherine; Chen, Tzu-An; Virtanen, Jyrki K; Wong, Kerry; Bassett, Julie K; Murphy, Rachel; Tintle, Nathan; Yu, Chaoyu Ian; Brouwer, Ingeborg A; Chien, Kuo-Liong; Chen, Yun-Yu; Wood, Alexis C; Del Gobbo, Liana C et al [incl. Laakso, Markku; Tuomainen, Tomi-Pekka; Uu. 2020. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies PLoS medicine 17 6: e1003102. 2020

Uusitupa, Matti; Schwab, Ursula. 2019. Kalaöljyt ja sydäntautien ehkäisy Duodecim 135 10: 905-907. 2019

Uusitupa, Matti. 2019. Good news from the Da Qing Diabetes Prevention Outcome Study-healthy lifestyles result in long-term cardiovascular benefits Annals of translational medicine 7 Supplement 8: S368. 2019

Uusitupa, M; Khan, TA; Viguiliouk, E; Kahleova, H; Rivellese, AA; Hermansen, K; Pfeiffer, A; Thanopoulou, A; Salas-Salvadó, J; Schwab, U; Sievenpiper, JL. 2019. Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis Nutrients 11 11: 2611. 2019

Ulven, SM; Holven, KB; Rundblad, A; Myhrstad, MCW; Leder, L; Dahlman, I; Mello, VD; Schwab, U; Carlberg, C; Pihlajamäki, J; Hermansen, K; Dragsted, LO; Gunnarsdottir, I; Cloetens, L; Åkesson, B; Rosqvist, F; Hukkanen, J; Herzig, KH; Savolainen, MJ; Risérus, U; et al. [incl. Uusitupa, M]. 2019. An Isocaloric Nordic Diet Modulates RELA and TNFRSF1A Gene Expression in Peripheral Blood Mononuclear Cells in Individuals with Metabolic Syndrome-A SYSDIET Sub-Study Nutrients 11 12: 2932. 2019

Tuomainen, M; Kärkkäinen, O; Leppänen, J; Auriola, S; Lehtonen, M; Savolainen, MJ; Hermansen, K; Risérus, U; Åkesson, B; Thorsdottir, I; Kolehmainen, M; Uusitupa, M; Poutanen, K; Schwab, U; Hanhineva, K. 2019. Quantitative assessment of betainized compounds and associations with dietary and metabolic biomarkers in the randomized study of the healthy Nordic diet (SYSDIET) American journal of clinical nutrition 110 5: 1108-1118. 2019

Myhrstad, MC; de Mello, VD; Dahlman, I; Kolehmainen, M; Paananen, J; Rundblad, A; Carlberg, C; Olstad, OK; Pihlajamäki, J; Holven, KB; Hermansen, K; Dragsted, LO; Gunnarsdottir, I; Cloetens, L; Storm, MU; Åkesson, B; Rosqvist, F; Hukkanen, J; et al. (incl. Schwab, U; Uusitupa, M). 2019. Healthy Nordic Diet Modulates the Expression of Genes Related to Mitochondrial Function and Immune Response in Peripheral Blood Mononuclear Cells from Subjects with the Metabolic Syndrome - A SYSDIET Sub-Study Molecular nutrition and food research 63 13: 1801405. 2019

Marklund, M; Wu, JHY; Imamura,;F, Del Gobbo, LC; Fretts, A; de Goede, J; Shi, P; Tintle, N; Wennberg, M; Aslibekyan, S; Chen, TA; de Oliveira Otto, MC; Hirakawa, Y; Eriksen, HH; Kröger, J; Jaguzzi, F; Lankinen, M; Murphy, Rachel A; Prem, Kiesha; Samieri, Cécilia; et al. (incl. Uusitupa, M; Mursu J; Laakso, M; Virtanen, J). 2019. Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies Circulation 139 21: 2422-2436. 2019

Lankinen, Maria; Uusitupa, Matti; Schwab, Ursula. 2019. Nordic Diet and Inflammation - A Review of Observational and Intervention Studies Nutrients 11 6: 1369. 2019

Justice, AE; Karaderi, T; Highland, HM; Young, KL; Graff, M; Lu, Y; Turcot, V; Auer, PL; Fine, RS; Guo, X; Schurmann, C; Lempradl, A; Marouli, E; Mahajan, A; Winkler, TW; Locke, AE; Medina-Gomez, C; Esko, T; Vedantam, S; Giri, A; Lo, KS; et al. (Incl. Kuusisto, Johanna; Laakso, Markku; Lakko, Timo; Uusitupa, Matti; Vanhala, Mauno). 2019. Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution Nature genetics 51: 452-469. 2019

Fretts, AM; Imamura, F; Marklund, M; Micha, R; Wu, JHY; Murphy, RA; Chien, KL; McKnight, B; Tintle, N; Forouhi, NG; Qureshi, WT; Virtanen, JK; Wong, K; Wood, AC; Lankinen, M; Rajaobelina, K; Harris, TB; et al (incl; Laakso, M; Uusitupa, M; Voutilainen, S). 2019. Associations of circulating very-long-chain saturated fatty acids and incident type 2 diabetes: a pooled analysis of prospective cohort studies American journal of clinical nutrition 109 4: 1216-1223. 2019

Aro, A; Kauppinen, A; Kivinen, N; Selander, T; Kinnunen, K; Tuomilehto, J; Keinänen-Kiukaanniemi, S; Lindström, J; Uusitupa, M; Kaarniranta, K. 2019. Life Style Intervention Improves Retinopathy Status - The Finnish Diabetes Prevention Study Nutrients 11 7: 1691. 2019

Tuomainen, Marjo; Lindström, Jaana; Lehtonen, Marko; Auriola, Seppo; Pihlajamäki, Jussi; Peltonen, Markku; Tuomilehto, Jaakko; Uusitupa, Matti; de Mello, Vanessa D; Hanhineva, Kati. 2018. Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals Nutrition and diabetes 8: 35. 2018

Uusitupa, Matti; Schwab, Ursula. 2018. Keinotekoiset makeutteet Lääkärilehti 73 15: 926-930. 2018

Uusitupa, Matti; Mustajoki, Pertti. 2018. Varhainen laihdutus voi kääntää tyypin 2 diabeteksen remissioon Lääkärilehti 73 14: 825-825a. 2018

Uusitupa, Matti; Lindström, Jaana; Tuomilehto, Jaakko. 2018. Prevention of type 2 diabetes - success story that is waiting for next steps European journal of clinical nutrition 72: 1260-1266. 2018

Uusitupa, Matti. 2018. Remission of type 2 diabetes : mission not impossible. LANCET 391 10120: 515-516. 2018

Imamura, F; Fretts, A; Marklund, M; Ardisson Korat, AV; Yang, WS; Lankinen, M; Qureshi, W; Helmer, C; Chen, TA; Wong, K; Bassett, JK; Murphy, R; Tintle, N; Yu, CI; Brouwer, IA; Chien, KL; Frazier-Wood, AC; Del Gobbo, LC; Djoussé, L; Geleijnse, JM; et al (incl. Lankinen, Maria; Laakso, Markku; Uusitupa, Matti). 2018. Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies PLoS medicine 15 10: e100267. 2018

Ruuth, M; Nguyen, SD; Vihervaara, T; Hilvo, M; Laajala, TD; Kondadi, PK; Gisterå, A; Lähteenmäki, H; Kittilä, T; Huusko, J; Uusitupa, M; Schwab, U; Savolainen, MJ; Sinisalo, J; Lokki, ML; Nieminen, MS; Jula, A; Perola, M; Ylä-Herttula, S; Rudel, L; et al.. 2018. Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths EUROPEAN HEART JOURNAL 39 27: 2562-2573. 2018

Aregbesola, A; de Mello, VDF; Lindström, J; Voutilainen, S; Virtanen, JK; Keinänen-Kiukaanniemi, S; Tuomainen, TP; Tuomilehto, J; Uusitupa, M. 2018. Serum Adiponectin/Ferritin Ratio in Relation to the Risk of Type 2 diabetes and Insulin Sensitivity. DIABETES RESEARCH AND CLINICAL PRACTICE 141: 264-274. 2018

Rintala, A; Riikonen, I; Toivonen, A; Pietilä, S; Munukka, E; Pursiheimo, JP; Elo, LL; Arikoski, P; Luopajärvi, K; Schwab, U; Uusitupa, M; Heinonen, S; Savilahti, E; Eerola, E; Ilonen, J. 2018. Early fecal microbiota composition in children who later develop celiac disease and associated autoimmunity SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 53 4: 403-409. 2018

Kärkkäinen, O; Lankinen, MA; Vitale, M; Jokkala, J; Leppänen, J; Koistinen, V; Lehtonen, M; Giacco, R; Rosa-Sibakov, N; Micard, V; Rivellese, AAA; Schwab, U; Mykkänen, H; Uusitupa, M; Kolehmainen, M; Riccardi, G; Poutanen, K; Auriola, S; Hanhineva, K. 2018. Diets rich in whole grains increase betainized compounds associated with glucose metabolism American journal of clinical nutrition 108 5: 971-979. 2018

Lankinen, Maria; Uusitupa, Matti; Schwab, Ursula. 2018. Genes and Dietary Fatty Acids in Regulation of Fatty Acid Composition of Plasma and Erythrocyte Membrane Nutrients 10 11: 1785. 2018

Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M, Guo X, Hendricks AE, Karaderi T, Lempradl A, Locke AE, Mahajan A, Marouli E, Sivapalaratnam S, Young KL, Alfred T et al. (incl. Laakso Markku, Lakka Timo, Uusitupa Matti). 2017. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity NATURE GENETICS 50; 2018 1: 26-41. 2017

Walle P, Takkunen M, Männistö V, Vaittinen M, Käkelä P, Ågren J, Schwab U, Lindström J, Tuomilehto J, Uusitupa M, Pihlajamäki J. 2017. Alterations in fatty acid metabolism in response to obesity surgery combined with dietary counseling. NUTRITION AND DIABETES 7 9: e285. 2017

Uusitupa Matti. 2017. Potkiiko SOTE myös liikkumaan. LIIKUNTA JA TIEDE 54 5/2017: 42-44. 2017

Manning A, Highland HM, Gasser J, Sim X, Tukiainen T, Fontanillas P, Grarup N, Rivas MA, Mahajan A, Locke AE, Cingolani P, Pers TH, Viñuela A, Brown AA, Wu Y, Flannick J, Fuchsberger C, Gamazon ER, Gaulton KJ, Im HK et al. (incl. Lakka Timo, Kuulasmaa Teemu, Laakso Markku, Uusitupa Matti). 2017. A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. DIABETES (NY) 66 7: 2019-2032. 2017

Instability of LDL particles predicts future cardiovascular deaths. Ruuth M, Nguyen SD, Vihervaara T, Hilvo M, Laajala TD, Kondadi PK, Anton G, Huusko J, Uusitupa M, Schwab U, Lawrence R, Ketelhuth D, Laaksonen R, Baumann M, Aittokallio T, Jauhiainen M, Jan B, Williams KJ, Kovanen P, Öörni K. Atherosclerosis. 2017. 2017

de Mello VD, Paananen J, Lindstrom J, Lankinen MA, Shi L, Kuusisto J, Pihlajamaki J, Auriola S, Lehtonen M, Rolandsson O, Bergdahl IA, Nordin E, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Landberg R, Eriksson JG, Tuomilehto J, Hanhineva K, Uusitupa M. 2017. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Scientific Reports 7: 46337. 2017

de Mello VD, Lankinen MA, Lindström J, Puupponen-Pimiä R, Laaksonen DE, Pihlajamäki J, Lehtonen M, Uusitupa M, Tuomilehto J, Kolehmainen M, Törrönen R, Hanhineva K. 2017. Fasting serum hippuric acid is elevated after bilberry (Vaccinium myrtillus) consumption and associates with improvement of fasting glucose levels and insulin secretion in persons at high risk of developing type 2 diabetes. Molecular Nutrition & Food Research 61 9: 1700019. 2017

Uusitupa Matti, Rautalahti Matti, Vartiainen Erkki. 2017. Painopiste preventioon!. DUODECIM 133 12: 1125-1126. 2017

Ried JS, Jeff M J, Chu AY, Bragg-Gresham JL, van Dongen J, Huffman JE, Ahluwalia TS, Cadby G, Eklund N, Eriksson J, Esko T, Feitosa MF, Goel A, Gorski M, Hayward C, Heard-Costa NL, Jackson AU, Jokinen E, Kanoni S, Kristiansson K et al. 2016. A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape. Nature Communications 7: 13357. 2016

Zanoni Paolo, Khetarpal Sumeet A, Larach Daniel B, Hancock-Cerutti William F, Millar John S, Cuchel Marina, DerOhannessian Stephanie, Kontush Anatol, Surendran Praveen, Saleheen Danish, Trompet Stella, Jukema J Wouter, De Craen Anton, Deloukas Panos, Sattar Naveed, Ford Ian, Packard Chris, Majumder Abdullah al Shafi , Alam Dewan S, Di Angelantonio Emanuele et al. 2016. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. SCIENCE 351 6278: 1166-1171. 2016

Winkler Thomas W, Justice Anne E, Graff Mariaelisa, Barata Llilda, Feitosa Mary F, Chu Su, Czajkowski Jacek, Esko Tõnu, Fall Tove, Kilpeläinen Tuomas O, Lu Yingchang, Mägi Reedik, Mihailov Evelin, Pers Tune H, Rüeger Sina, Teumer Alexander, Ehret Georg B, Ferreira Teresa, Heard-Costa Nancy L, Karjalainen Juha et al. 2016. Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLOS GENETICS [ONLINE) 12 6: e1006166. 2016

Uusitupa, Matti. 2016. Liikuntalääketiede nyt!. LIIKUNTA JA TIEDE 53 6: 83. 2016

Uusitupa Matti. 2016. Lifestyle changes and cardiovascular risk reduction in diabetes. The Lancet Diabetes & Endocrinology 4 11: 877-878. 2016

Uusitupa Matti. 2016. Hälsofrämjande nordiska kostvanor - senaste framstegen och framtida forskningsutmaningar. Nordisk Nutrition 3: 27-30. 2016

Surendran P, Drenos F, Young R, Warren H, Cook JP, Manning AK, Grarup N, Sim X, Barnes DR, Witkowska K, Staley JR, Tragante V, Tukiainen T, Yaghootkar H, Masca N, Freitag DF, Ferreira T, Giannakopoulou O, Tinker A, Harakalova M et al. 2016. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. NATURE GENETICS 48: 1151-1161. 2016

Lindström Jaana, Uusitupa Matti, Tuomilehto Jaakko, Peltonen Markku. 2016. Following in the Footsteps of the North Karelia Project: Prevention of Type 2 Diabetes. Global Heart 11 2: 223-228. 2016

Livingstone KM, Celis-Morales C, Papandonatos GD, Erar B, Florez JC, Jablonski KA, Razquin C, Marti A, Heianza Y, Huang T, Sacks FM, Svendstrup M, Sui X, Church TS, Jääskeläinen T, Lindström J, Tuomilehto J, Uusitupa M, Rankinen T, Saris WH et al.. 2016. FTO genotype and weight loss: systematic review and meta-analysis of 9563 individual participant data from eight randomised controlled trials. The BMJ 354: i4707. 2016

Lehtisalo J, Lindström J, Ngandu T, Kivipelto M, Ahtiluoto S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Eriksson JG, Uusitupa M, Tuomilehto J, Luchsinger J. 2016. Association of long-term dietary fat intake, exercise, and weight with later cognitive function in the Finnish Diabetes Prevention Study. JOURNAL OF NUTRITION, HEALTH & AGING 20 2: 146-154. 2016

Leder Lena, Kolehmainen Marjukka, Narverud Ingunn, Dahlman Ingrid, Myhrstad Mari CW, de Mello Vanessa D, Paananen Jussi, Carlberg Castren, Schwab Ursula, Herzig Karl-Heinz, Cloetens Lieselotte, Storm Matilda Ulmius, Hukkanen Janne, Savolainen Markku J, Rosqvist Fredrik, Hermansen Kjeld, Dragsted Lars O, Gunnarsdottir Ingibjörk, Thorsdottir Inga, Risérus Ulf et al.. 2016. Effects of a healthy Nordic diet on gene expression changes in peripheral blood mononuclear cells in response to an oral glucose tolerance test in subjects with metabolic syndrome: a SYSDIET sub-study. Genes and Nutrition 11 3: 1-13. 2016

Lankinen Maria, Schwab Ursula, Kolehmainen Marjukka, Paananen Jussi, Nygren Heli, Seppänen-Laakso Tuulikki, Poutanen Kaisa, Hyötyläinen Tuulia, Risérus Ulf, Savolainen Markku J, Hukkanen Janne, Brader Lea, Marklund Matti, Rosqvist Fredrik, Hermansen Kjeld, Cloetens Lieselotte, Önning Gunilla, Thorsdottir Inga, Gunnarsdottir Ingibjork, Åkesson Björn et al. 2016. A Healthy Nordic Diet Alters the Plasma Lipidomic Profile in Adults with Features of Metabolic Syndrome in a Multicenter Randomized Dietary Intervention. JOURNAL OF NUTRITION 146 4: 662-672. 2016

Hinney A, Kesselmeier M, Jall S, Volckmar AL, Föcker M, Antel J, Heid IM, Winkler TW, Grant SF, Guo Y, Bergen AW, Kaye W, Berrettini W, Hakonarson H, Herpertz-Dahlmann B, de Zwaan M, Herzog W, Ehrlich S, Zipfel S, Egberts KM et al., GCAN, WTCCC3, EGG, GIANT, Price Foundation Collaborative Group, Children's Hospital of Philadelphia/Price Foundation. 2016. Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index. MOLECULAR PSYCHIATRY 2017; 22: 192-201. 2016

Ehret GB, Ferreira T, Chasman DI, Jackson AU, Schmidt EM, Johnson T, Thorleifsson G, Luan J, Donnelly LA, Kanoni S, Petersen AK, Pihur V, Strawbridge RJ, Shungin D, Hughes MF, Meirelles O, Kaakinen M, Bouatia-Naji N, Kristiansson K, Shah S et al.. 2016. The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. NATURE GENETICS 48 10: 1171-1184. 2016

Liikuntalääketieteen yhteiskunnallisen merkityksen ja liikuntalääketieteen keskusten toiminnan arviointi (2006 - 2016). Uusitupa Matti. 2016 2016

Vaittinen Maija, Kolehmainen Marjukka, Rydén Mikael, Eskelinen Matti, Wabitsch Martin, Pihlajamäki Jussi, Uusitupa Matti, Pulkkinen Leena. 2015. MFAP5 is Related to Obesity-Associated Adipose Tissue and Extracellular Matrix Remodeling and Inflammation. OBESITY (SILVER SPRING, MD.) 23 7: 1371-1378. 2015

Takkunen Markus J, Schwab Ursula S, de Mello Vanessa DF, Eriksson Johan G, Lindström Jaana, Tuomilehto Jaakko, Uusitupa Matti IJ, the DPS Study Group. 2015. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study. EUROPEAN JOURNAL OF NUTRITION 2016; 55 3: 967-979. 2015

Tuomainen Tomi-Pekka, Virtanen Jyrki K, Voutilainen Sari, Nurmi Tarja, Mursu Jaakko, de Mello Vanessa DF, Schwab Ursula, Hakumäki Martti, Pulkki Kari, Uusitupa Matti. 2015. Glucose Metabolism Effects of Vitamin D in Prediabetes: the VitDmet Randomized Placebo-Controlled Supplementation Study. Journal of Diabetes Research 2015: 8 pages. 2015

Uusitpa Matti. 2015. Suomalaisen ravitsemustutkimuksen tähtihetkiä. DUODECIM 131 20: 1865-1871. 2015

Wu H, Kolehmainen M, Mykkänen H, Poutanen K, Uusitupa M, Schwab U, Wolk A, Landberg R. 2015. Alkylresorcinols in adipose tissue biopsies as biomarkers of whole-grain intake: an exploratory study of responsiveness to advised intake over 12 weeks. EUROPEAN JOURNAL OF CLINICAL NUTRITION 69 11: 1244-1248. 2015

Vukic Maja, Neme Antonio, Seuter Sabine, Saksa Noora, de Mello Vanessa DF, Nurmi Tarja, Uusitupa Matti, Tuomainen Tomi-Pekka, Virtanen Jyrki K, Carlberg Carsten. 2015. Relevance of Vitamin D Receptor Target Genes for Monitoring the Vitamin D Responsiveness of Primary Human Cells. PLOS ONE [ONLINE] 10 4: e0124339. 2015

Wikström K, Lindström J, Tuomilehto J, Saaristo TE, Helakorpi S, Korpi-Hyövälti E, Oksa H, Vanhala M, Keinänen-Kiukaanniemi S, Uusitupa M, Peltonen M. 2015. National diabetes prevention program (DEHKO): awareness and self-reported lifestyle changes in Finnish middle-aged population. PUBLIC HEALTH 129 3: 210-217. 2015

Winkler Thomas W, Justice Anne E, Graff Mariaelisa, Barata Llilda, Feitosa Mary F, Chu Su, Czajkowski Jacek, Esko Tõnu, Fall Tove, Kilpeläinen Tuomas O, Lu Yingchang, Mägi Reedik, Mihailov Evelin, Pers Tune H, Rüeger Sina, Teumer Alexander, Ehret Georg B, Ferreira Teresa, Heard-Costa Nancy L, Karjalainen Juha et al. 2015. The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLOS GENETICS [ONLINE) 11 10: e1005378. 2015

Zimmermann E, Angquist LH, Mirza SS, Zhao JH, Chasman DI, Fischer K, Qi Q, Smith AV, Thinggaard M, Jarczok MN, Nalls MA, Trompet S, Timpson NJ, Schmidt B, Jackson AU, Lyytikäinen LP, Verweij N, Mueller-Nurasyid M, Vikström M et al. 2015. Is the adiposity-associated FTO gene variant related to all-cause mortality independent of adiposity? Meta-analysis of data from 169,551 Caucasian adults. Obesity Reviews 16 4: 327-340. 2015

Shungin Dmitry, Winkler Thomas W, Croteau-Chonka Damien C, Ferreira Teresa, Locke Adam E, Mägi Reedik, Strawbridge Rona J, Pers Tune H, Fischer Krista, Justice Anne E, Workalemahu Tsegaselassie, Wu Joseph MW, Buchkovich Martin L, Heard-Costa Nancy L, Roman Tamara S, Drong Alexander W, Song Ci, Gustafsson Stefan, Day Felix R, Esko Tonu et al. 2015. New genetic loci link adipose and insulin biology to body fat distribution. NATURE (LONDON) 518 7538: 187-196. 2015

Takkunen Markus J, de Mello Vanessa D, Schwab Ursula S, Kuusisto Johanna, Vaittinen Maija, Ågren Jyrki J, Laakso Markku, Pihlajamäki Jussi, Uusitupa MI. 2015. Gene-diet interaction of a common FADS1 variant with marine polyunsaturated fatty acids for fatty acid composition in plasma and erythrocytes among men. Molecular Nutrition & Food Research 2016; 60 2: 381-389. 2015

Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Puolijoki H, Tuomilehto J, Vanhala M, Moilanen L, Uusitupa M, Keinänen-Kiukaanniemi S. 2015. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme. DIABETIC MEDICINE [epub ahead of print 8 May 2015]: -. 2015

Schwab Ursula, Uusitupa Matti. 2015. Diet heart controversies - Quality of fat matters. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 25 7: 617-622. 2015

Pihlajamäki Jussi, Schwab Ursula, Kaminska Dorota, Ågren Jyrki, Kuusisto Johanna, Kolehmainen Marjukka, Paananen Jussi, Laakso Markku, Uusitupa Matti. 2015. Dietary polyunsaturated fatty acids and the Pro12Ala polymorphisms of PPARG regulate serum lipids through divergent pathways: a randomized crossover clinical trial. Genes and Nutrition 10 6: 43. 2015

Pers Tune H, Karjalainen Juha M, Chan Yingleong, Westra Harm-Jan, Wood Andrew R, Yang Jian, Lui Julian C, Vedantam Sailaja, Gustafsson Stefan, Esko Tonu, Frayling Tim, Speliotes Elizabeth K, Genetic Investigation of ANthropometric Traits (GIANT) Consortium (incl. Johanna Kuusisto, Markku Laakso, Timo Lakka, Matti Uusitupa), Boehnke Michael, Raychaudhuri Soumya, Fehrmann Rudolf SN, Hirschhorn Joel . 2015. Biological interpretation of genome-wide association studies using predicted gene functions. Nature Communications 6: 5890. 2015

Mahajan Anubha, Sim Xueling, Ng Hui Jin, Manning Alisa, Rivas Manuel A, Highland Heather M, Locke Adam E, Grarup Niels, Im Hae Kyung, Cingolani Pablo, Flannick Jason, Fontanillas Pierre, Fuchsberger Christian, Gaulton Kyle J, Teslovich Tanya M, Rayner N William, Robertson Neil R, Beer Nicola L, Rundle Jana K, Bork-Jensen Jette et al. On Behalf of the T2D-GENES consortium and GoT2D consortium. 2015. Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLOS GENETICS [ONLINE) 11 1: e1004876. 2015

Luchsinger José A, Lehtisalo Jenni, Lindström Jaana, Ngandu Tiia, Kivipelto Miia, Ahtiluoto Satu, Ilanne-Parikka Pirjo, Keinänen-Kiukaanniemi Sirkka, Eriksson Johan G, Uusitupa Matti, Tuomilehto Jaakko, for the Finnish Diabetes Prevention Study (DPS). 2015. Cognition in the Finnish Diabetes Prevention Study. DIABETES RESEARCH AND CLINICAL PRACTICE 108 3: e63-e66. 2015

Locke Adam E, Kahali Bratati, Berndt Sonja I, Justice Anne E, Pers Tune H, Day Felix R, Powell Corey, Vedantam Sailaja, Buchkovich Martin L, Yang Jian, Croteau-Chonka Damien C, Esko Tonu, Fall Tove, Ferreira Teresa, Gustafsson Stefan, Kutalik Zoltán, Luan Jian'an, Mägi Reedik, Randall Joshua C, Winkler Thomas W et al. 2015. Genetic studies of body mass index yield new insights for obesity biology. NATURE (LONDON) 518 7538: 197-206. 2015

Lehtisalo Jenni, Lindström Jaana, Ngandu Tiia, Kivipelto Miia, Ahtiluoto Satu, Ilanne-Parikka Pirjo, Keinänen-Kiukaanniemi Sirkka, Eriksson Johan G., Uusitupa Matti, Tuomilehto Jaakko, Luchsinger Jose A, for the Finnish Diabetes Prevention Study (DPS). 2015. Diabetes, glycaemia, and cognition - a secondary analysis of the Finnish Diabetes Prevention Study. DIABETES/METABOLISM RESEARCH AND REVIEWS [epub ahead of print 18 AUG 2015]: -. 2015

Lankinen Maria A., Hanhineva Kati, Kolehmainen Marjukka, Lehtonen Marko, Auriola Seppo, Mykkänen Hannu, Poutanen Kaisa, Schwab Ursula, Uusitupa Matti. 2015. CMPF Does Not Associate with Impaired Glucose Metabolism in Individuals with Features of Metabolic Syndrome. PLOS ONE [ONLINE] 10 4: e0124379. 2015

Lankinen Maria A, Stancáková Alena, Uusitupa Matti, Ågren Jyrki, Pihlajamäki Jussi, Kuusisto Johanna, Schwab Ursula, Laakso Markku. 2015. Plasma fatty acids as predictors of glycaemia and type 2 diabetes. DIABETOLOGIA 58 11: 2533-2544. 2015

Lammi Anne, Arikoski Pekka, Hakulinen Arja, Schwab Ursula, Uusitupa Matti, Heinonen Seppo, Savilahti Erkki, Kinnunen Tuure, Ilonen Jorma. 2015. Development of gliadin-specific immune responses in children with HLA-associated genetic risk for celiac disease. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 2016; 51 2: 168-177. 2015

de Mello VDF, Lindström J, Eriksson JG, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Pihlajamäki J, Tuomilehto J, Uusitupa M. 2015. Markers of cholesterol metabolism as biomarkers in predicting diabetes in the Finnish Diabetes Prevention Study. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 25 7: 635-642. 2015

Tuomilehto Henri, Uusitupa Matti. 2014. Lifestyle Changes Aiming at Weight Loss Should Always Be Included in the Treatment of Obese Patients with Obstructive Sleep Apnea. SLEEP 37 5: 1021. 2014

Saksa Noora, Neme Antonio, Ryynänen Jussi, Uusitupa Matti, de Mello Vanessa DF, Voutilainen Sari, Nurmi Tarja, Virtanen Jyrki K, Tuomainen Tomi-Pekka, Carlberg Carsten. 2014. Dissecting high from low responders in a vitamin D3 intervention study. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY Epub ahead of print: -. 2014

Schwab Ursula, Lauritzen Lotte, Tholstrup Tine, Haldorsson Thorhallur I, Riserus Ulf, Uusitupa Matti, Becker Wulf. 2014. Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type-2 diabetes, cardiovascular disease, and cancer: a systematic review. FOOD & NUTRITION RESEARCH 58 25145: -. 2014

Takkunen MJ, de Mello VDF, Schwab US, Ågren JJ, Kuusisto J, Uusitupa MIJ. 2014. Associations of erythrocyte membrane fatty acids with the concentrations of C-reactive protein, interleukin 1 receptor antagonist and adiponectin in1373 men. PROSTAGLANDINS, LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 91: 169-174. 2014

Tuomilehto Henri, Seppä Juha, Uusitupa Matti, Peltonen Markku, Martikainen Tarja, Sahlman Johanna, Kokkarinen Jouko, Randell Jukka, Pukkila Matti, Vanninen Esko, Tuomilehto Jaakko, Gylling Helena. 2014. The impact of weight reduction in the prevention of the progression of obstructive sleep apnea: an explanatory analysis of a 5-year observational follow-up trial. SLEEP MEDICINE 15 3: 329-335. 2014

Wood Andrew R, Esko Tonu, Yang Jian, Vedantam Sailaja, Pers Tune H, Gustafsson Stefan, Chu Audrey Y, Estrada Karol, Luan Jian'an, Kutalik Zoltán, Amin Najaf, Buchkovich Martin L, Croteau-Chonka Damien C, Day Felix R, Duan Yanan, Fall Tove, Fehrmann Rudolf, Ferreira Teresa, Jackson Anne U, Karjalainen Juha et.al.. 2014. Defining the role of common variation in the genomic and biological architecture of adult human height. NATURE GENETICS 46 11: 1173-86. 2014

Uusitupa Matti, Lindström Jaana, Tuomilehto Jaakko. 2014. Diabetesepidemia on vielä ehkäistävissä. SUOMEN LÄÄKÄRILEHTI 69 20: 1454-1455. 2014

Uusitupa Matti, Schwab Ursula. 2014. Ruokavalio ja lievä tulehdus. DUODECIM 130: 9-11. 2014

van Vliet-Ostaptchouk Jana V, Nuotio Marja-Liisa, Slagter Sandra N, Doiron Dany, Fischer Krista, Foco Luisa, Gaye Amadou, Gögele Martin, Heier Margit, Hiekkalinna Tero, Joensuu Anni, Newby Christopher, Pang Chao, Partinen Eemil, Reischl Eva, Schwienbacher Christine, Tammesoo Mari-Liis, Swertz Morris A, Burton Paul, Ferretti Vincent et.al.. 2014. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC ENDOCRINE DISORDERS 14 9: 1-13. 2014

Wilfinger Julia, Seuter Sabine, Tuomainen Tomi-Pekka, Virtanen Jyrki K, Voutilainen Sari, Nurmi Tarja, de Mello Vanessa DF, Uusitupa Matti, Carlberg Carsten. 2014. Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system. JOURNAL OF NUTRITIONAL BIOCHEMISTRY 25 8: 875-884. 2014

Winkler Thomas W, Day Felix R, Croteau-Chonka Damien C, Wood Andrew R, Locke Adam E, Mägi Reedik, Ferreira Teresa, Fall Tove, Graff Mariaelisa, Justice Anne E, Luan Jian'an, Gustafsson Stefan, Randall Joshua C, Vedantam Sailaja, Workalemahu Tsegaselassie, Kilpeläinen Tuomas O, Scherag André, Esko Tonu, Kutalik Zoltán, Heid Iris M, The Genetic Investigation of Anthropometric Traits (GIANT) Consorti. 2014. Quality control and conduct of genome-wide association meta-analyses. NATURE PROTOCOLS 9 5: 1192-1212. 2014

Rautio N, Jokelainen J, Pölönen A, Oksa H, Peltonen M, Vanhala M, Puolijoki H, Moilanen L, Tuomilehto J, Uusitupa M, Keinänen-Kiukaanniemi S, Saaristo T. 2014. Changes in lifestyle modestly reduce the estimated cardiovascular disease risk in one-year follow-up of the Finnish diabetes prevention program (FIN-D2D). EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING Epub ahead of print: -. 2014

Ryynänen Jussi, Neme Antonio, Tuomainen Tomi-Pekka, Virtanen Jyrki K, Voutilainen Sari, Nurmi Tarja, de Mello Vanessa DF, Uusitupa Matti, Carlberg Carsten. 2014. Changes in vitamin D target gene expression in adipose tissue monitor the vitamin D response of human individuals. Molecular Nutrition & Food Research 58: 2036-2045. 2014

Rautio Nina, Jokelainen Jari, Korpi-Hyövälti Eeva, Oksa Heikki, Saaristo Timo, Peltonen Markku, Moilanen Leena, Vanhala Mauno, Uusitupa Matti, Tuomilehto Jaakko, Keinänen-Kiukaanniemi Sirkka. 2014. Lifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project. Journal of Women's Health 23 6: 506-12. 2014

Rahmioglu Nilufer, Macgregor Stuart, Drong Alexander W, Hedman Åsa K, Harris Holly R, Randall Joshua C, Prokopenko Inga, The International EndoGene Consortium (IEC), The GIANT Consortium, Nyholt Dale R, Morris Andrew P, Montgomery Grant W, Missmer Stacey A, Lindgren Cecilia M, Zondervan Krina T. 2014. Genome-wide Enrichment Analysis between Endometriosis and Obesity-related Traits Reveals Novel Susceptibility Loci. HUMAN MOLECULAR GENETICS Epub ahead of print: -. 2014

Kolehmainen Marjukka, Ulven Stine M, Paananen Jussi, de Mello Vanessa, Schwab Ursula, Carlberg Carsten, Myhrstad Mari, Pihlajamäki Jussi, Dungner Elisabeth, Sjölin Eva, Gunnarsdottir Ingibjörg, Cloetens Lieselotte, Landin-Olsson Mona, Akesson Björn, Rosqvist Fredrik, Hukkanen Janne, Herzig Karl-Heinz, Dragsted Lars O, Savolainen Markku J, Brader Lea, Hermansen Kjeld, Risérus Ulf, Thorsdottir Inga,. 2014. Healthy Nordic diet downregulates the expression of genes involved in inflammation in subcutaneous adipose tissue in individuals with features of the metabolic syndrome. AMERICAN JOURNAL OF CLINICAL NUTRITION 101 1 (2015): 228-239. 2014

Brader Lea, Rejnmark Lars, Carlberg Carsten, Schwab Ursula, Kolehmainen Marjukka, Rosqvist Fredrik, Cloetens Lieselotte, Landin-Olsson Mona, Gunnarsdottir Ingibjorg, Poutanen Kaisa S, Herzig Karl-Heinz, Risérus Ulf, Savolainen Markku J, Thorsdottir Inga, Uusitupa Matti, Hermansen Kjeld. 2014. Effects of a healthy Nordic diet on plasma 25-hydroxyvitamin D concentration in subjects with metabolic syndrome: a randomized, placebo-controlled trial (SYSDIET). EUROPEAN JOURNAL OF NUTRITION 53 4: 1123-34. 2014

Qi Qibin, Kilpeläinen Tuomas O, Downer Mary K, Tanaka Toshiko, Smith Caren E, Sluijs Ivonne, Sonerstedt Emily, Chu Audrey Y, Renström Frida, Lin Xiaochen, Ängquist Lars H, Huang Jinyan, Liu Zhonghua, Li Yanping, Asif Ali Muhammad, Xu Min, Singh Ahluwalia Tarunweer, Boer Jolanda MA, Chen Peng, Daimon Makoto et.al.. 2014. FTO genetic variants, dietary intake and body mass index: insights from 177 330 individuals. HUMAN MOLECULAR GENETICS Epub ahead of print: -. 2014

de Mello Vanessa Derenji Ferreira, Pulkkinen Leena, Lalli Marianne, Kolehmainen Marjukka, Pihlajamäki Jussi, Uusitupa Matti. 2014. DNA methylation in obesity and type 2 diabetes. Annals of Medicine 46: 103-113. 2014

Hanhineva Kati, Lankinen Maria A, Pedret Anna, Schwab Ursula, Kolehmainen Marjukka, Paananen Jussi, de Mello Vanessa, Sola Rosa, Lehtonen Marko, Poutanen Kaisa, Uusitupa Matti, Mykkänen Hannu. 2014. Nontargeted metabolite profiling discriminates diet-specific biomarkers for consumption of whole grains, fatty fish, and bilberries in a randomized controlled trial. JOURNAL OF NUTRITION 2015; 145: 7-17. 2014

Helisalmi Seppo, Immonen Ilkka, Losonczy Gergely, Resch Miklos D, Benedek Szabolcs, Balogh Istvan, Papp Andras, Berta Andras, Uusitupa Matti, Hiltunen Mikko, Kaarniranta Kai. 2014. ADAMTS9 locus associates with increased risk of wet AMD. ACTA OPHTHALMOLOGICA 2014: 1. 2014

Hoggart Clive J, Venturini Giulia, Mangino Massimo, Gomez Felicia, Ascari Giulia, Zhao Jing Hua, Teumer Alexander, Winkler Thomas W, Tšernikova Natalia, Luan Jian'an, Mihailov Evelin, Ehret Georg B, Zhang Weihua, Lamparter David, Esko Tõnu, Macé Aurelian, Rüeger Sina, Bochud Pierre-Yves, Barcella Matteo, Dauvilliers Yves et al (including Atalay Mustafa, Kuusisto Johanna, Lakka Timo, Yaluri Alena, . 2014. Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index. PLOS GENETICS [ONLINE) 10 7: e1004508. 2014

Cloetens Lieselotte, Johansson-Persson Anna, Helgegren Hannah, Landin-Olsson Mona, Uusitupa Matti, Åkesson Björn, Önning Gunilla. 2014. Assessment of Body Composition in Subjects with Metabolic Syndrome Comparing Single-Frequency Bioelectrical Impedance Analysis and Bioelectrical Spectroscopy. METABOLIC SYNDROME AND RELATED DISORDERS Epub ahead of print: -. 2014

Lankinen Maria, Kolehmainen Marjukka, Jääskeläinen Tiina, Paananen Jussi, Joukamo Laura, Kangas Antti J, Soininen Pasi, Poutanen Kaisa, Mykkänen Hannu, Gylling Helena, Orešic Matej, Jauhiainen Matti, Ala-Korpela Mika, Uusitupa Matti, Schwab Ursula. 2014. Effects of whole grain, fish and bilberries on serum metabolic profile and lipid transfer protein activities: a randomized trial (Sysdimet). PLOS ONE [ONLINE] 9 2: e90352. 2014

Magnusdottir OK, Landberg R, Gunnarsdottir I, Cloetens L, Åkesson B, Landin-Olsson M, Rosqvist F, Iggman D, Schwab U, Herzig K-H, Savolainen MJ, Brader L, Hermansen K, Kolehmainen M, Poutanen K, Uusitupa M, Thorsdottir I, Risérus U. 2014. Plasma alkylresorcinols C17:0/C21:0 ratio, a biomarker of relative whole-grain rye intake, is associated to insulin sensitivity: a randomized study. EUROPEAN JOURNAL OF CLINICAL NUTRITION 68: 453-458. 2014

Magnusdottir Ola Kally, Landberg Rikard, Gunnarsdottir Ingibjorg, Cloetens Lieselotte, Åkesson Björn, Rosqvist Fredrik, Schwab Ursula, Herzig Karl-Heinz, Hukkanen Janne, Savolainen Markku J, Brader Lea, Hermansen Kjeld, Kolehmainen Marjukka, Poutanen Kaisa, Uusitupa Matti, Risérus Ulf, Thorsdottir Inga. 2014. Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome - a randomized study. PLOS ONE [ONLINE] 9 10: e110827. 2014

Marklund Matti, Magnusdottir Ola K, Rosqvist Fredrik, Cloetens Lieselotte, Landberg Rikard, Kolehmainen Marjukka, Brader Lea, Hermansen Kjeld, Poutanen Kaisa S, Herzig Karl-Heinz, Hukkanen Janne, Savolainen Markku J, Dragsted Lars O, Schwab Ursula, Paananen Jussi, Uusitupa Matti, Åkesson Björn, Thorsdottir Inga, Risérus Ulf. 2014. A dietary biomarker approach captures compliance and cardiometabolic effects of a healthy nordic diet in individuals with metabolic syndrome. JOURNAL OF NUTRITION 144 10: 1642-1649. 2014

Miettinen Maija E, Kinnunen Leena, Leiviskä Jaana, Keinänen-Kiukaanniemi Sirkka, Korpi-Hyövälti Eeva, Niskanen Leo, Oksa Heikki, Saaristo Timo, Tuomilehto Jaakko, Vanhala Mauno, Uusitupa Matti, Peltonen Markku. 2014. Association of serum 25-hydroxyvitamin D with lifestyle factors and metabolic and cardiovascular disease markers: population-based cross-sectional study (FIN-D2D). PLOS ONE [ONLINE] 9 7: e100235. 2014

Lind Marcus, Tuomilehto Jaakko, Uusitupa Matti, Nerman Olle, Eriksson Johan, Ilanne-Parikka Pirjo, Keinänen-Kiukaanniemi Sirkka, Peltonen Markku, Pivodic Aldina, Lindström Jaana. 2014. The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes. PLOS ONE [ONLINE] 9 10: e109506. 2014

Uusitupa M, Hermansen K, Savolainen MJ, Schwab U, Kolehmainen M, Brader L, Mortensen LS, Cloetens L, Johansson-Persson A, Önning G, Landin-Olsson M, Herzig K-H, Hukkanen J, Rosqvist F, Iggman D, Paananen J, Pulkki KJ, Siloaho M, Dragsted L, Barri T et.al.. 2013. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome - a randomized study (SYSDIET). JOURNAL OF INTERNAL MEDICINE 274: 52-66. 2013

Rautio N, Jokelainen J, Oksa H, Saaristo T, Moilanen L, Vanhala M, Peltonen M, Korpi-Hyövälti E, Tuomilehto J, Uusitupa M, Timonen M, Keinänen-Kiukaanniemi S. 2013. Do depressive symptoms have an impact on the effectiveness of lifestyle counseling in prevention of type 2 diabetes? One-year follow-up of FIN-D2D. PRIMARY CARE DIABETES - -: -. 2013

Rautio N, Jokelainen J, Saaristo T, Oksa H, Keinänen-Kiukaanniemi S; for the FIN-D2D writing group. 2013. Predictors of success of a lifestyle intervention in relation to weight loss and improvement in glucose tolerance among individuals at high risk for type 2 diabetes: the FIN-D2D project. JOURNAL OF PRIMARY CARE & COMMUNITY HEALTH 4 1: 59-66. 2013

Takkunen M, Ågren J, Kuusisto J, Laakso M, Uusitupa M, Schwab U. 2013. Dietary fat in relation to erythrocyte fatty acid composition in men. LIPIDS 48: 1093-1102. 2013

Tolppanen Anna-Maija, Lavikainen Piia, Solomon Alina, Kivipelto Miia, Uusitupa Matti, Soininen Hilkka, Hartikainen Sirpa. 2013. History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study. DIABETES CARE 36: 2015-2019. 2013

Tuomilehto H, Seppä J, Uusitupa M, Tuomilehto J, Gylling H for the Kuopio Sleep Apnea Group. 2013. Weight reduction and increased physical activity to prevent the progression of obstructive sleep apnea: a 4-year observational postintervention follow-up of randomized clinical trial. Jama Internal Medicine 173 10: 929-930. 2013

Vaittinen M, Kaminska D, Käkelä P, Eskelinen M, Kolehmainen M, Pihlajamäki J, Uusitupa M, Pulkkinen L. 2013. Downregulation of CPPED1 expression improves glucose metabolism in vitro in adipocytes. DIABETES (NY) 62: 3747-3750. 2013

Uusitupa M, Kolehmainen M, Schwab U, Poutanen K. 2013. Kohti terveellistä pohjoismaista ruokavaliota. KEHITTYVÄ ELINTARVIKE 2: 48-50. 2013

Uusitupa M, Schwab U. 2013. Diet, inflammation and prediabetes - impact of quality of diet. Canadian Journal of Diabetes 37: 327-331. 2013

Virtanen JK, Mursu J, Voutilainen S, Uusitupa M, Tuomainen T-P. 2013. Serum Omega-3 Polyunsaturated Fatty Acids and Risk of Incident Type 2 Diabetes in Men: The Kuopio Ischaemic Heart Disease Risk Factor Study. DIABETES CARE 37 2: 189-196. 2013

Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, Mora S, Beckmann JS, Bragg-Gresham JL, Chang H-Y, Demirkan A, Den Hertog HM, Do R, Donnelly LA, Ehret GB, Esko T, Feitosa MF et.al.. 2013. Discovery and refinement of loci associated with lipid levels. NATURE GENETICS 45 11: 1274-1283. 2013

Wu Y, Waite LL, Jackson AU, Sheu WH, Buyske S, Absher D, Arnett DK, Boerwinkle E, Bonnycastle LL, Carty CL, Cheng I, Cochran B, Croteau-Chonka DC, Dumitrescu L, Eaton CB, Franceschini N, Guo X, Henderson BE, Hindorff LA, Kim E, et al. (including Stancakova A, Kuusisto J, Laakso M, Uusitupa M, Rauramaa R Lakka T.). 2013. Trans-Ethnic Fine-Mapping of Lipid Loci Identifies Population-Specific Signals and Allelic Heterogeneity That Increases the Trait Variance Explained. PLOS GENETICS [ONLINE) 9 3: e1003379. 2013

Penn L, White M, Lindström J, den Boer AT, Blaak E, Eriksson JG, Feskens E, Ilanne-Parikka P, Keinänen-Kiukaanniemi SM, Walker M, Mathers JC, Uusitupa M, Tuomilehto J. 2013. Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT. PLOS ONE [ONLINE] 8 2: e57143. 2013

Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL, Kilpeläinen TO, Esko T, Mägi R, Li S, Workalemahu T, Feitosa MF, Croteau-Chonka DC, Day FR, Fall T, Ferreira T, Gustafsson S, Locke AE, Mathieson I, Scherag A, et al. (including J Kuusisto, M Laakso, M Atalay, T Lakka). 2013. Sex-stratified Genome-wide Association Studies Including 270,000 Individuals Show Sexual Dimorphism in Genetic Loci for Anthropometric Traits. PLOS GENETICS [ONLINE) 9 6: e1003500. 2013

Brader L, Uusitupa M, Dragsted LO, Hermansen K. 2013. Effects of an isocaloric healthy Nordic diet on ambulatory blood pressure in metabolic syndrome: a randomized SYSDIET sub-study. EUROPEAN JOURNAL OF CLINICAL NUTRITION [Epub ahead of print]: x-x. 2013

Miettinen M, Kinnunen L, Keinänen-Kiukaanniemi S, Korpi-Hyövälti E, Niskanen L, Oksa H, Saaristo T, Sundvall J, Tuomilehto J, Vanhala M, Uusitupa M, Peltonen M. 2013. D-vitamiinin puutos on yleistä suomalaisessa aikuisväestössä - D2D-väestötutkimus 2007. SUOMEN LÄÄKÄRILEHTI 68 4: 211-15. 2013

Hu Y-J, Berndt SI, Gustafsson S, Ganna A, Genetic Investigation of ANthropometric Traits (GIANT) Consortium (including M Atalay, T Lakka, J Kuusisto, M Laakso), Hirschhorn J, North KE, Ingelsson E, Lin D-Y et.al.. 2013. Meta-analysis of gene-level associations for rare variants based on single-variant statistics. AMERICAN JOURNAL OF HUMAN GENETICS 93 2: 236-248. 2013

Avramoglu RK, Laplante M-A, Quang KL, Deshaies Y, Despres J-P, Larose E, Mathieu P, Poirier P, Perusse L, Vohl M-C, Sweeney G, Ylä-Herttuala S, Laakso M, Uusitupa M, Marette A. 2013. The Genetic and Metabolic Determinants of Cardiovascular Complications in Type 2 Diabetes: Recent Insights from Animal Models and Clinical Investigations. Canadian Journal of Diabetes 37 5: 351-358. 2013

Mahendran Yuvaraj, Cederberg Henna, Vangipurapu Jagadish, Kangas Antti J, Soininen Pasi, Kuusisto Johanna, Uusitupa Matti, Ala-Korpela Mika, Laakso Markku. 2013. Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men. DIABETES CARE 36: 3732-3738. 2013

Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, Mora S, Beckmann JS, Bragg-Gresham JL, Chang H-Y, Demirkan A, Den Hertog HM, Donnelly LA, Ehret GB, Esko T et.al.. 2013. Common variants associated with plasma triglycerides and risk for coronary artery disease. NATURE GENETICS 45 11: 1345-52. 2013

Erkkilä AT, Schwab US, Lehto S, de Mello VD, Kangas AJ, Soininen P, Ala-Korpela M, Uusitupa MIJ. 2013. Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: A controlled trial. Journal of Clinical Lipidology online [Epub ahead of print]: -. 2013

Giacco R, Lappi J, Costabile G, Kolehmainen M, Schwab U, Landberg R, Uusitupa M, Poutanen K, Pacini G, Rivellese AA, Riccardi G, Mykkänen H. 2013. Effects of rye and whole wheat versus refined cereal foods on metabolic risk factors: A randomised controlled two-centre intervention study. CLINICAL NUTRITION online: x-x. 2013

Berndt SI, Gustafsson S, Mägi R, Ganna A, Wheeler E, Feitosa MF, Justice AE, Monda KL, Croteau-Chonka DC, Day FR, Esko T, Fall T, Ferreira T, Gentilini D, Jackson AU, Luan J, Randall JC, Vedantam S, Willer CJ, Winkler TW, et al. (including Atalay M, Kuusisto J, Lakka TA, Stancakova A, Laakso M, Uusitupa M). 2013. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. NATURE GENETICS 45 5: 501-512. 2013

Jonsdottir SE, Brader L, Gunnarsdottir I, Magnusdottir OK, Schwab U, Kolehmainen M, Risérus U, Herzig K-H, Cloetens L, Helgegren H, Johansson-Persson A, Hukkanen J, Poutanen K, Uusitupa M, Hermansen K, Thorsdottir I. 2013. Adherence to the Nordic Nutrition Recommendations in a Nordic population with metabolic syndrome: high salt consumption and low dietary fibre intake (The SYSDIET study). FOOD & NUTRITION RESEARCH 57: 21391. 2013

Jääskeläinen T, Paananen J, Lindström J, Eriksson JG, Tuomilehto J, Uusitupa M. 2013. Genetic predisposition to obesity and lifestyle factors - the combined analyses of twenty-six known BMI- and fourteen known waist:hip ratio (WHR)-associated variants in the Finnish Diabetes Prevention Study. BRITISH JOURNAL OF NUTRITION 110: 1856-1965. 2013

Käkelä P, Jääskeläinen T, Torpström J, Ilves I, Venesmaa S, Pääkkönen M, Gylling H, Paajanen H, Uusitupa M, Pihlajamäki J. 2013. Genetic risk score does not predict the outcome of obesity surgery. OBESITY SURGERY online 2014 Jan;24(1):128-33.: -. 2013

Magnusdottir OK, Landberg R, Gunnarsdottir I, Cloetens L, Åkersson B, Önning G, Jonsdottir SE, Rosqvist F, Schwab U, Herzig K-H, Savolainen MJ, Brader L, Hermansen K, Kolehmainen M, Poutanen K, Uusitupa M, Thorsdottir I, Risérus U. 2013. Plasma alkylresorcinols reflect important whole-grain components of a healthy nordic diet. JOURNAL OF NUTRITION 143 9: 1383-1390. 2013

Magnusdottir OK, Landberg R, Gunnarsdottir I, Cloetens L, Åkesson B, Önning G, Jonsdottir SE, Rosqvist F, Schwab U, Herzig KH, Savolainen MJ, Brader L, Hermansen K, Kolehmainen M, Poutanen K, Uusitupa M, Thorsdottir I, Risérus U. 2013. Alkylresorcinols and A-carotene in plasma as dietary biomarkers for healthy nordic diet. ANNALS OF NUTRITION & METABOLISM 63: 459. 2013

Mahendran Y, Ågren J, Uusitupa M, Cederberg H, Vangipurapu J, Stancakova A, Schwab U, Kuusisto J, Laakso M. 2013. Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. AMERICAN JOURNAL OF CLINICAL NUTRITION -: -. 2013

Joukamo L, Lankinen M, Schwab U, Soininen P, Kangas AJ, Kolehmainen M, Paananen J, Poutanen K, Mykkänen H, Seppänen-Laakso T, Gylling H, Oresic M, Ala-Korpela M, Uusitupa M. 2013. Rasvainen kala muokkaa HDL-hiukkaskokoa ja lipidipitoisuuksia. DUODECIM 129: 2661-70. 2013

Uusitupa M, Schwab U. 2012. Ravintolisien lääkinnällinen käyttö. NIVELTIETO 4: 18-21. 2012

Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, Mägi R, Strawbridge RJ, Rehnberg E, Gustafsson S, Kanoni S, Rasmussen-Torvik L, Yengo L, Lecoeur C, Shungin D, Sanna S, Sidore C, Johnson PCD, Jukema JW, Johnson T et.al.. 2012. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. NATURE GENETICS 44 9: 991-1005. 2012

Simonen M, Dali-Youcef N, Kaminska D, Venesmaa S, Käkelä P, Pääkkönen M, Hallikainen M, Kolehmainen M, Uusitupa M, Moilanen L, Laakso M, Gylling H, Patti ME, Auwerx J, Pihlajamäki J. 2012. Conjugated Bile Acids Associate with Altered Rates of Glucose and Lipid Oxidation after Roux-en-Y Gastric Bypass. OBESITY SURGERY 22 9: 1473-1480. 2012

Tuomilehto H, Seppä J, Uusitupa M. 2012. Obesity and obstructive sleep apnea - Clinical significance of weight loss. Sleep Medicine Reviews online [Epub ahead of print]: -. 2012

Uusitupa M, Fogelholm M. 2012. Ravitsemustilan arviointi. Teoksessa: Aro A, Mutanen M, Uusitupa M (toim.), Ravitsemustiede.Duodecim. ss. 204-209. 2012

Uusitupa M, Schwab U. 2012. Ravintolisien lääkinnällinen käyttö. ERIKOISLÄÄKÄRI 22 1: 14-18. 2012

Uusitupa M. 2012. Ravitsemus, kihti ja reumataudit. Teoksessa: Aro M, Mutanen M, Uusitupa M (toim.), Ravitsemustiede. ss. 477-480. 2012

Uusitupa M. 2012. Lihavuuden, tyypin 2 diabeteksen ja metabolisen oireyhtymän ehkäisy. Teoksessa: Aro A, Mutanen M, Uusitupa M (toim.), Ravitsemustiede.Duodecim. ss. 306-309. 2012

Uusitupa M. 2012. Lihavuus. Teoksessa: Aro A, Mutanen M, Uusitupa M (toim.), Ravitsemustiede.Duodecim. ss. 347-367. 2012

Uusitupa M. 2012. Ravitsemus ja diabetes. Teoksessa: Aro A, Mutanen M, Uusitupa M (toim.), Ravitsemustiede. ss. 368-396. 2012

Uusitupa M. 2012. Sydämen vajaatoiminnan ravitsemushoito. Teoksessa: Aro A, Mutanen M, Uusitupa M (toim.), Ravitsemustiede. ss. 475-476. 2012

Uusitupa Matti. 2012. Ruokavalio diabeteksen ehkäisyssä ja hoidossa. MEDIUUTISET 39: 8-9. 2012

Ravitsemustiede. Aro A, Mutanen M, Uusitupa M. 2012 2012

Ruusunen A, Voutilainen S, Karhunen L, Lehto S. M., Tolmunen T, Keinänen-Kiukaanniemi S, Eriksson J, Tuomilehto J, Uusitupa M and Lindström J. 2012. How does lifestyle intervention affect depressive symptoms? Results from the Finnish Diabetes Prevention Study. DIABETIC MEDICINE 29 7: e126-32. 2012

Eriksson JG, Gelow J, Thornburg KL, Osmond C, Laakso M, Uusitupa M, Lindi V, Kajatie E, Barker DJP. 2012. Long-term effects of placental growth on overweight and body composition. International journal of pediatrics 2012 2012:324185 Epub 2012 Apr 18.: 6 pages. 2012

Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Vanhala M, Puolijoki H, Moilanen L, Tuomilehto J, Keinänen-Kiukaanniemi S, Uusitupa M. 2012. Do statins interfere with lifestyle intervention in the prevention of diabetes in primary healthcare? One-year follow-up of the FIN-D2D project. BMJ Open 2: -. 2012

Kaarniranta K, Paananen J, Nevalainen T, Sorri I, Seitsonen S, Immonen I, Salminen A, Pulkkinen L, Uusitupa M. 2012. Adiponectin receptor 1 gene (ADIPOR1) variant is associated with advanced age-related macular degeneration in Finnish population. NEUROSCIENCE LETTERS 513 2: 233-237. 2012

de Mello Laaksonen VD, Lindström J, Eriksson J, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Sundvall J, Laakso M, Tuomilehto J, Uusitupa M. 2012. Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the finnish diabetes prevention study DIABETES CARE 35: 211-217. 2012

de Mello VDF, Kolehmainen M, Schwab U, Pulkkinen L, Uusitupa M. 2012. Gene expression of peripheral blood mononuclear cells as a tool in dietary intervention studies: What do we know so far?. Molecular Nutrition & Food Research 56: 1160-1172. 2012

Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, Rudling M, Arner P, Cederholm T, Ahlström H, Risérus U. 2012. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. AMERICAN JOURNAL OF CLINICAL NUTRITION 95 5: 1003-12. 2012

Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Puolijoki H, Tuomilehto J, Vanhala M, Moilanen L, Uusitupa M, Keinänen-Kiukaanniemi S. 2012. Family history of diabetes and effectiveness of lifestyle counselling on the cardio-metabolic risk profile in individuals at high risk of Type 2 diabetes: 1-year follow-up of the FIN-D2D project DIABETIC MEDICINE 29: 207-211. 2012

Hovatta I, de Mello VDF, Kananen L, Lindström J, Eriksson JG, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Peltonen M, Tuomilehto J, Uusitupa M. 2012. Leukocyte Telomere Lenght in the Finnish Diabetes Prevention Study. PLOS ONE [ONLINE] 7 4: 1-6. 2012

Fogelholm M, Uusitupa M. 2012. Kehon koostumuksen arviointi. Teoksessa: Aro A, Mutanen M, Uusitupa M (toim.), Ravitsemustiede.Duodecim. ss. 196-203. 2012

Lappalainen Tiina, Lindström Jaana, Paananen Jussi, Eriksson Johan G, Karhunen Leila, Tuomilehto Jaakko, Uusitupa Matti for the Finnish Diabetes Prevention Study Group. 2012. Association of the fat mass and obesity-associated (FTO) gene variant (rs9939609) with dietary intake in the Finnish Diabetes Prevention Study. BRITISH JOURNAL OF NUTRITION 108 10: 1859-65. 2012

Lindström J, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J. 2012. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). DIABETOLOGIA online: -. 2012

Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, Rybin D, Liu CT, Bielak LF, Prokopenko I, Amin N, Barnes D, Cadby G, Hottenga JJ, Ingelsson E, Jackson AU, Johnson T, Kanoni S, Ladenvall C, Lagou V et.al.. 2012. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance NATURE GENETICS 44 6: 659-669. 2012

Mutanen M, Uusitupa M. 2012. Ravinto, geenien toiminta, genomiikka ja epigenetiikka. Teoksessa: Aro A, Mutanen M, Uusitupa M (toim.), Ravitsemustiede.Duodecim. ss. 168-182. 2012

Pajunen P, Keinänen-Kiukaanniemi S, Korpi-Hyövälti E, Männistö S, Niskanen L, Oksa H, Saaristo T, Saltevo J, Sundvall J, Vanhala M, Uusitupa M, Eriksson J, Peltonen M. 2012. Ylipainon ja lihavuuden esiintyvyys tyypin 2 diabetespotilailla. SUOMEN LÄÄKÄRILEHTI 67 38: 2621-2626. 2012

Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Niskanen L, Saltevo J, Korpi-Hyövälti E, Uusitupa M, Tuomilehto J, Keinänen-Kiukaanniemi S. 2012. Participation, socioeconomic status and group of individual counselling intervention in individuals at high risk for type 2 diabetes: One-year follow-up study of the FIN-D2D-project. PRIMARY CARE DIABETES 6 4: 277-283. 2012

Siitonen N, Pulkkinen L, Lindstrom J, Kolehmainen M, Schwab U, Eriksson JG, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M. 2011. Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study CARDIOVASCULAR DIABETOLOGY [ONLINE: HTTP://WWW.CARDIAB.COM/] 10 1: 83. 2011

Siitonen N, Pulkkinen L, Lindström J, Kolehmainen M, Eriksson JG, Venojärvi M, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J & Uusitupa M. 2011. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC MEDICAL GENETICS [ONLINE: HTTP://WWW.BIOMEDCENTRAL.COM/BMCMEDGENET/] 12: 5. 2011

Tolppanen AM, Helisalmi S, Hiltunen M, Kolehmainen M, Schwab U, Pirttilä T, Pulkkinen L, Uusitupa M & Soininen H.. 2011. Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort. Negative results. NEUROBIOLOGY OF AGING 32: 546.e7-546.e9. 2011

Uusitupa M, Tuomilehto J, Puska P. 2011. Are we really active in the prevention of obesity and type 2 diabetes at the community level?. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 21: 380-389. 2011

Uusitupa Matti, Lappalainen Tiina. 2011. Miksi kaikki eivät liho? SUOMEN LÄÄKÄRILEHTI 66 22: 1811-1812a. 2011

Uusitupa Matti, Raussi Emmikaisa. 2011. Solakaksi syömällä vai rajoittamalla hiilihydraatteja KEHITTYVÄ ELINTARVIKE 5: 12-15. 2011

Vaittinen M, Kolehmainen M, Schwab U, Uusitupa M, Pulkkinen L. 2011. Microfibrillar-associated protein 5 is linked with markers of obesity-related extracellular matrix remodeling and inflammation NUTRITION AND DIABETES 1: e15, 1-6. 2011

Uusitupa Matti, Schwab Ursula. 2011. Millainen on sydämelle terveellinen ruokavalio?. DUODECIM 127: 521-4. 2011

Uusitupa Matti, Tuomilehto Jaakko. 2011. Destiny in your own hands - Does a positive family history matter in the prevention of type 2 diabetes? PRIMARY CARE DIABETES 5: 213-214. 2011

Uusitupa Matti. 2011. Näkökulma. Karppaus - enemmän kuin muotivillitys? ERIKOISLÄÄKÄRI 4: 144-145. 2011

Uusitupa Matti. 2011. Ravitsemussuosituksien nykylinjat YK:n agendalla SYDÄN: SUOMEN SYDÄNTAUTILIITON JULKAISU 54 5: 7. 2011

Uusitupa MI, Stancáková A, Peltonen M, Eriksson JG, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M. 2011. Impact of positive family history and genetic risk variants on the incidence of diabetes - the Finnish Diabetes Prevention Study. DIABETES CARE Online January 2011: 1-6. 2011

Schwab U, Alfthan G, Aro A &Uusitupa M. 2011. Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects. EUROPEAN JOURNAL OF CLINICAL NUTRITION 65: 70-76. 2011

Schwab U, Alfthan G, Aro A, Uusitupa M. 2011. Response to Slow et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION 65: 772. 2011

Uusitupa Matti, Savolainen Markku. 2011. Mitä lihavuuden lääkehoidossa on luvassa? SUOMEN LÄÄKÄRILEHTI 66 39: 2864-2866. 2011

Saltevo JT, Kautiainen H, Niskanen L, Oksa H, Puolijoki H, Sundvall J, Keinänen-Kiukaanniemi S, Peltonen T, Tuomilehto J, Uusitupa M, Mäntyselkä P, Vanhala MJ. 2011. Ageing and associations of fasting plasma glucose and 2 h plasma glucose with HbA1g in apparently healthy population. " FIN-D2D" study DIABETES RESEARCH AND CLINICAL PRACTICE 93: 344-349. 2011

Lankinen Maria, Schwab Ursula, Kolehmainen Marjukka, Paananen Jussi, Poutanen Kaisa, Mykkänen Hannu, Seppänen-Laakso Tuulikki, Gylling Helena, Uusitupa Matti, Ore¿ič Matej. 2011. Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the sysdimet study. PLOS ONE [ONLINE] 6 8: e22646. 2011

Salopuro TM, Saaristo T, Oksa H, Puolijoki H, Vanhala M, Ebeling T, Niskanen L, Tuomilehto J, Uusitupa M, Peltonen M.. 2011. Population-level effects of the national diabetes prevention programme (FIN-D2D) on the body weight, the waist circumference, and the prevalence of obesity.. BMC PUBLIC HEALTH 11: 350. 2011

de Mello Vanessa D, Schwab Ursula, Kolehmainen Marjukka, Koenig W, Siloaho Maritta, Poutanen Kaisa, Mykkänen Hannu, Uusitupa Matti. 2011. A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: The Sysdimet study. DIABETOLOGIA 54: 2755-2767. 2011

Kilpeläinen Tuomas O, Qi Lu, Brage Soren, Sharp Stephen J., Sonestedt Emily, Demerath Ellen, Ahmad Tariq, Mora Samia, Kaakinen Marika, Sandholt Camilla H, Holzapfel Christina, Autenrieth Christine S., Hyppönen Elina, Cauchi Stéphane , He Meian, Kutalik Zoltan, Kumari Meena, Stancaková Alena, Meidtner Karina, Balkau Beverley et al.. 2011. Physical activity attenuates the influence of FTO variants on obesity risk: A meta-analysis of 218,166 adults and 19,268 children PLOS MEDICINE 8 11: e1001116. 2011

Kujala UM, Jokelainen J, Oksa H, Saaristo T, Rautio N, Moilanen L, Korpi-Hyövälti E, Saltevo J, Vanhala M, Niskanen L, Peltonen M, Tuomilehto J, Uusitupa M, Keinänen-Kiukaannemi S. 2011. Increase in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study among individuals at high risk for type 2 diabetes BMJ Open 1 2: e000292. 2011

Laitinen T, Lindström J, Eriksson J, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M. 2011. Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance. DIABETIC MEDICINE 28: 699-704. 2011

Family history of diabetes and effectiveness of lifestyle counselling on the cardiometabolic risk profile in individuals at high risk of type 2 diabetes: 1-year follow-up of the FIN-D2D project. Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Puolijoki H, Tuomilehto J,Vanhala M, Moilanen L, Uusitupa M, Keinänen-Kiukaanniemi S. 2011 2011

Pajunen P, Kotronen A, Korpi-Hyovalti E, Keinanen-Kiukaanniemi S, Oksa H, Niskanen L, Saaristo T, Saltevo JT, Sundvall J, Vanhala M, Uusitupa M, Peltonen M.. 2011. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC PUBLIC HEALTH 11: 754. 2011

Pedersen JI, James PT, Brouwer IA, Clarke R, Elmadfa I, Katan MB, Kris-Etherton PM, Kromhout D, Margetts BM, Mensink RP, Norum KR, Rayner M, Uusitupa M. 2011. The importance of reducing SFA to limit CHD BRITISH JOURNAL OF NUTRITION 106: 961-963. 2011

Pedersen JI, Norum KR, James PT, Brouwer IA, Katan MB, Clarke R, Elmadfa I, Kris-Etherton PM, Kromhout D, Margetts BM, Mensink RP, Rayner M, Uusitupa M. 2011. Response to Hoenselaar from Pedersen et al BRITISH JOURNAL OF NUTRITION online: 452-454. 2011

Pedersen JI, Norum KR, James PT, Brouwer IA, Katan MB, Clarke R, Elmadfa I, Kris-Etherton PM, Kromhout D, Margetts BM, Mensink RP, Rayner M, Uusitupa M.. 2011. Response to Ravnskov et al. on saturated fat and CHD BRITISH JOURNAL OF NUTRITION online: 458-460. 2011

Raussi Emmikaisa, Uusitupa Matti. 2011. Tepsiikö vähähiilihydraattinen ruokavalio lihavuuden hoidossa?. SUOMEN LÄÄKÄRILEHTI 66 37: 2659-2664a. 2011

Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Niskanen L, Puolojoki H, Vanhala M, Uusitupa M, Keinänen-Kiukaanniemi S. & on the belalf of FIN-D2D study group. 2011. Socioeconomic position and effectiveness of lifestyle intervention in prevention of type 2 diabetes: One-year follow-up of the FIN-D2D project. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH 39 6: 561-70. 2011

Pajunen P, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J & Lindström J: Finnish Diabetes Prevention Study. 2011. HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study. DIABETIC MEDICINE 28: 36-42. 2011

Tolppanen A-M, Kolehmainen M, Pulkkinen L & Uusitupa M. 2010. Tenomodulin gene and obesity-related phenolypes Annals of Medicine 42: 265-275. 2010

Sahlman J, Seppä J, Herder C, Peltonen M, Peuhkurinen K, Gylling H, Vanninen E, Tukiainen H, Punnonen K, Partinen M, Uusitupa M, Tuomilehto H.. 2010. Effect of weight loss on inflammation in patients with mild obstructive sleep apnea.. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES online: 1-8. 2010

Salopuro T, Saaristo T, Korpi-Hyövälti E, Oksa H, Keinänen-Kiukaanniemi S, Saltevo J, Vanhala M, Niskanen L, Moltchanova E, Sundvall J, Tuomilehto J, Uusitupa M, Peltonen M. 2010. Lihavuuden ja glukoosiaineenvaihdunnan häiriöiden esiintyvyydessä on selviä alueellisia eroja Suomessa SUOMEN LÄÄKÄRILEHTI 65 26-31: 2381-2388. 2010

Tammela LI , Pääkkönen A, Karhunen LJ, Karhu J, Uusitupa MIJ & Kuikka JT. 2010. Brain electrical activity during food presentation in obese binge-eating women CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING 30: 135-140. 2010

Uusitupa M, Lindström J, Tuomilehto J. 2010. Prevention strategies for type 2 diabetes should be based on evidence-based medical nutrition data.. DIABETOLOGIA 53: 1809-1810. 2010

Tuomilehto H, Gylling H, Peltonen M, Martikainen T, Sahlman J, Kokkarinen J, Randell J, Tukiainen H, Vanninen E, Partinen M, Tuomilehto J, Uusitupa M, Seppä J; for the Kuopio Sleep Apnea Group.. 2010. Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity-based lifestyle intervention: postinterventional follow-up.. AMERICAN JOURNAL OF CLINICAL NUTRITION 92: 688-696. 2010

Tuomilehto J, Uusitupa M. 2010. Tyypin 2 diabetes - vakava paikka. SUOMEN LÄÄKÄRILEHTI 65 26-31: 2345. 2010

Uusitupa Matti. 2010. Quality of diet is important for the prevention of cardiovascular disease.. JOURNAL OF INTERNAL MEDICINE 269 2: 148-9. 2010

Wikström K, Lindström J, Tuomilehto J, Saaristo TE, Korpi-Hyövälti E, Oksa H, Vanhala M, Niskanen L, Keinänen-Kiukaanniemi S, Uusitupa M, Peltonen M. 2010. Socio-economic differences in dysglycemia and lifestyle-related risk factors in the Finnish middle-aged population.. EUROPEAN JOURNAL OF PUBLIC HEALTH online: 1-7. 2010

Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, Jokelainen J, Peltonen M, Oksa H, Tuomilehto J, Uusitupa M, Keinänen-Kiukaanniemi S.. 2010. Lifestyle intervention for prevention of type 2 diabetes in primary health care. DIABETES CARE 33 10: 2146-2151. 2010

Sahlman J, Miettinen K, Peuhkurinen K, Seppä J, Peltonen M, Herder C, Punnonen K, Vanninen E, Gylling H, Partinen M, Uusitupa M, Tuomilehto H; Kuopio Sleep Apnoea Group. 2010. The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea.. Journal of Sleep Research 19: 341-348. 2010

Pihlajamäki J, Grönlund S, Simonen M, Käkelä P, Moilanen L, Pääkkönen M, Pirinen E, Kolehmainen M, Kärjä V, Kainulainen S, Uusitupa M, Alhava E, Miettinen TA, Gylling H. 2010. Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding Metabolism: clinical and experimental 59: 866-872. 2010

Saaristo T, Moilanen L, Jokelainen J, Oksa H, Korpi-Hyövälti E, Saltevo J, Vanhala M, Niskanen L, Peltonen M, Tuomilehto J, Uusitupa M, Keinänen-Kiukaanniemi S. 2010. Diabetesriskiä voidaan vähentää perusterveydenhuollon keinoin. Taudin ilmaantuvuus pieneni D2D-hankkeessa.. SUOMEN LÄÄKÄRILEHTI 65: 2369-2379. 2010

Kilpeläinen TO, Laaksonen DE, Lakka TA, Herder C, Koenig W, Lindström J, Eriksson JG, Uusitupa M, Kolb H, Laakso M, Tuomilehto J, for the Finnish Diabetes Prevention Study Group. 2010. The rs1800629 polymorphism in the TNF gene interacts with physical activity on the changes in C-reactive protein levels in the Finnish diabetes prevention study. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY AND DIABETES 118 10: 757-759. 2010

Best of sleep medicine 2010. Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea.. Ed. Lee-Chiong T. Contributors: Tuomilehto HPI, Seppä JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JO, Vanninen EJ, Kokkarinen J, Sahlman JK, et.al.. 2010 2010

Ilanne-Parikka P, Laaksonen DE, Eriksson JG, Lakka TA, Lindström J, Peltonen M, Aunola S, Keinänen-Kiukaanniemi S, Uusitupa M & Tuomilehto J. On behalf of the Finnish diabetes prevention study group. 2010. Leisure-time physical activity and the metabolic syndrome in the Finnish diabetes prevention study. DIABETES CARE 33 7: 1610-1617. 2010

Saaristo T, Moilanen L, Jokelainen J, Oksa H, Korpi-Hyövälti E, Saltevo J, Vanhala M, Niskanen L, Peltonen M, Tuomilehto J, Uusitupa M & Keinänen-Kiukaanniemi S. 2010. Diabetesriskia voidaan vähentää perusterveydenhuollon keinoin. Taudin ilmaantuvuus pieneni D2D-hankkeessa. SUOMEN LÄÄKÄRILEHTI 65 26-31: 2369-2379. 2010

Karhunen LJ, Juvonen KR, Flander SM, Liukkonen K-H, Lähteenmäki L, Siloaho M, Laaksonen DE, Hetzig K-H, Uusitupa MI & Poutanen KS. 2010. A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. JOURNAL OF NUTRITION 140: 737-744. 2010

Juvonen K, Salmenkallio-Marttila M, Lyly M, Liukkonen KH, Lähteenmäki L, Laaksonen D, Uusitupa M, Herzig K, Poutanen K & Karhunen L. 2010. Semisolid meal enriched in oat bran decreases plasma glucose and insulin levels, but does not change gastrointestinal peptide responses or short-term appetite in healthy subjects. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 21/2011: 2011/748-756. 2010

Lappalainen T, Kolehmainen M, Schwab U, Pulkkinen L, de Mello VD, Vaittinen M, Laaksonen DE, Poutanen K, Uusitupa M, Gylling H. 2010. Gene Expression of FTO in Human Subcutaneous Adipose Tissue, Peripheral Blood Mononuclear Cells and Adipocyte Cell Line. Journal of Nutrigenet Nutrigenomics 3 1: 37-45. 2010

Lappalainen T, Kolehmainen M, Schwab US, Tolppanen AM, Stančáková A, Lindström J, Eriksson JG, Keinänen-Kiukaanniemi S, Aunola S, Ilanne-Parikka P, Herder C, Koenig W, Gylling H, Kolb H &Tuomilehto J for the Finnish diabetes prevention study group. 2010. Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism - The Finnish Diabetes Prevention Study. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 2011/21: 691-698/2011. 2010

Lundbom J, Kolehmainen M Pulkkinen L, Soininen P , Tiainen M, Schwab U, Uusitupa M & Tammi M. 2010. Mid-infrared spectroscopy and multivariate curve resolution EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY 112: 1308-1314. 2010

Pulkkinen L, Ukkola O, Kolehmainen M, Uusitupa M. 2010. Ghrelin in diabetes and metabolic syndrome. INTERNATIONAL JOURNAL OF PEPTIDES 2010: ID 248948, 11 PAGES. 2010

Saaristo T, Moilanen L, Jokelainen J, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, Peltonen M, Oksa H, Cederberg H, Tuomilehto J, Uusitupa M, Keinänen-Kiukaanniemi S. 2010. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D) PRIMARY CARE DIABETES 4: 231-239. 2010

Wikström K, Peltonen M, Eriksson JG, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J, Lindström J. 2009. Educational attainment and effectiveness of lifestyle intervention in the Finnish diabetes prevention study. DIABETES RESEARCH AND CLINICAL PRACTICE 86: e1-e5. 2009

Uusitupa M, Peltonen M, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Valle TT, Eriksson JG, Tuomilehto J, for the Finnish Diabetes Prevention Study Group. 2009. Ten-year morality and cardiovaskular morabidity in the Finnish diabetes prevention study - secondary analysis of the randomized trial PLOS ONE [ONLINE] 4: e5656. 2009

Tuomilehto HPI, Seppä JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JOI, Vanninen EJ, Kokkarinen J, Sahlman JK, Martikainen T, Soini EJO, Randell J, Tukiainen H, Uusitupa M, on behalf of the Kuopio Sleep Apnea Group. 2009. Lifestyle intervention with weight reduction. First line treatment in mild obstructive sleep apnea. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 179 4: 320-327. 2009

Tuomilehto H, Seppä J, Partinen M, Uusitupa M. 2009. From the Authors: Avoiding the supine posture during sleep for patients with mild obstructive sleep apnea. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 180: 101-102. 2009

Tuomilehto H, Seppä J, Gylling H, Uusitupa M. 2009. Obstruktiivinen uniapnea ja lihavuus. DUODECIM 125: 931-933. 2009

Tuomilehto H, Seppä J, Gylling H, Uusitupa M. 2009. From the authors: Long-term weight loss and maintenance in morbidly obese individuals wih obstructive sleep apnea. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 180: 191. 2009

Tuomilehto H, Peltonen M, Partinen M, Lavigne G, Eriksson JG, Herder C, Aunola S, Keinänen-Kiukaanniemi S, Ilanne-Parikka P, Uusitupa M, Tuomilehto J, Lindström J, on behalf of the Finnish diabetes prevention study group. 2009. Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance. The Finnish diabetes prevention study. DIABETES CARE 32 11: 1965-1971. 2009

Salopuro T, Pulkkinen L, Lindström J, Kolehmainen M, Tolppanen A-M, Eriksson JG, Valle TT, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M, Salopuro T, Pulkkinen L, Kolehmainen M, Tolppanen A-M, Uusitupa M. 2009. Variation in the UCP2 and UCP3 genes associated with abdominal obesity and serum lipids: The Finnish diabetes prevention study. BMC MEDICAL GENETICS [ONLINE: HTTP://WWW.BIOMEDCENTRAL.COM/BMCMEDGENET/] 10 94: [13 p.]. 2009

Tolppanen A-M, Nevalainen T, Kolehmainen M, Seitsonen S, Immonen I, Uusitupa M, Kaarniranta K, Pulkkinen L, Tolppanen A-M, Kolehmainen M, Uusitupa M, Pulkkinen L. 2009. Single nucleotide polymorphisms of the tenomodulin gene (TNMD) in age-related macular degeneration MOLECULAR VISION [ONLINE: HTTP://WWW.MOLVIS.ORG/MOLVIS/] 15: 762-770. 2009

Kallio P, Tolppanen A-M, Kolehmainen M, Poutanen K, Lindström J, Tuomilehto J, Kuulasmaa T, Kuusisto J, Pulkkinen L, Uusitupa M, Kallio P, Tolppanen A-M, Kolehmainen M, Poutanen K, Pulkkinen L, Uusitupa M. 2009. Association of sequence variations in the gene encoding insulin-like growth factor binding protein 5 with adiponectin. INTERNATIONAL JOURNAL OF OBESITY 33: 80-88. 2009

Kalesnykiene V, Sorri I, Voutilainen R, Uusitupa M, Niskanen L, Uusitalo H, Uusitupa M. 2009. The effect of glycaemic control on the quantitative characteristics of retinopathy lesions in patients with type 2 diabetes mellitus: 10-year follow-up study. GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 247: 335-341. 2009

Juvonen KR, Purhonen A-K, Salmenkallio-Marttila M, Lähteenmäki L, Laaksonen DE, Herzig K-H, Uusitupa MIJ, Poutanen KS, Karhunen LJ, Juvonen KR, Uusitupa MIJ, Poutanen KS. 2009. Viscosity of oat bran-enriched beverages influences gastrointestinal hormonal responses in healthy humans1-3. JOURNAL OF NUTRITION 139: 461-466. 2009

Herder C, Peltonen M, Koenig W, Sütfels K, Lindström J, Martin S, Ilanne-Parikka P, Eriksson JG, Aunola S, Keinänen-Kiukaanniemi S, Valle TT, Uusitupa M, Kolb H, Tuomilehto J, for the Finnish Diabetes Prevention Study Group. 2009. Anti-inflammatory effect of lifestyle changes in the Finnish diabetes prevention study. DIABETOLOGIA 52: 433-442. 2009

De Mello VDF, Lankinen M, Schwab U, Kolehmainen M, Lehto S, Seppä-Laakso T, Oresic M, Pulkkinen L, Uusitupa M, Erkkilä AT, De Mello VDF, Lankinen M, Schwab U, Kolehmainen M, Pulkkinen L, Uusitupa M. 2009. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. DIABETOLOGIA 52: 2612-2615. 2009

De Mello VDF, Erkkilä AT, Schwab US, Pulkkinen L, Kolehmainen M, Atalay M, Mussalo H, Lankinen M, Oresic M, Lehto S, Uusitupa M, De Mello VDF, Schwab US, Pulkkinen L, Kolehmainen M, Lankinen M, Uusitupa M. 2009. The effect of fatty or lean fish intake on inflammatory gene expression in peripheral blood mononuclear cells of patients with coronary heart disease. EUROPEAN JOURNAL OF NUTRITION 48: 447-455. 2009

Lankinen M, Schwab U, Erkkilä A, Seppänen-Laakso T, Hannila M-L, Mussalo H, Lehto S, Uusitupa M, Gylling H, Oresic M. 2009. Fatty fish intake decreases lipids related to inflammation and insulin signaling-A lipidomics approach. PLOS ONE [ONLINE] 4 e5258: [1-9]. 2009

Mager U, Degenhardt T, Pulkkinen L, Kolehmainen M, Tolppanen A-M, Lindström J, Eriksson JG, Carlberg, Tuomilehto J, Uusitupa M, for the Finnish Diabetes Prevention Study Group. 2008. Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance PLOS ONE [ONLINE] 3 8: e2941. 2008

Lindi V, Schwab U, Louheranta A, Vessby B, Hermansen K, Tapsell L, Riccardi G, Rivellese AA, Laakso M, Uusitupa MIJ, KANWU Study Group. 2008. The G-250A polymorphism in the hepatic lipase gene promotor is associated with changes in hepatic lipase activity and LDL cholesterol:The KANWU study. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 18: 88-95. 2008

Lindström J, Peltonen M, Eriksson JG, Aunola S, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J, for the Finnish Diabetes Prevention Study (DPS) group. 2008. Determinants for the effectiveness of lifestyle intervention in the Finnish diabetes prevention study. DIABETES CARE 31 5: 857-862. 2008

Lindström J, Uusitupa M. 2008. Lifestyle intervention, diabetes, and cardiovascular disease LANCET 371: 1731-1733. 2008

Tolppanen AM, Pulkkinen L, Herder C, Koenig W, Kolehmainen M, Lindström J, Tuomilehto J, Uusitupa M. 2008. The genetic variation of the tenomodulin gene (TNMD) is associated with serum levels of systemic immune mediators--the Finnish Diabetes Prevention Study. GENETICS IN MEDICINE 10 7: 536-544. 2008

Mager U, Kolehmainen M, de Mello VDF, Schwab U, Laaksonen DE, Rauramaa R, Gylling G, Atalay M, Pulkkinen L, Uusitupa M, Mager U, Kolehmainen M, Ferreira, Schwab U, Gylling H, Pulkkinen L, Uusitupa M. 2008. Expression of ghrelin gene in peripheral blood mononuclear cells and plasma ghrelin concentrations in patients with metabolic syndrome. EUROPEAN JOURNAL OF ENDOCRINOLOGY 158: 499-510. 2008

Schwab U, Seppänen-Laakso T, Yetukuri L, Ågren J, Kolehmainen M, Laaksonen DE, Ruskeepää A-L, Gylling H, Uusitupa M, Oresic M, for the Genobin Study Group, Schwab U, Kolehmainen M, Gylling H, Uusitupa M. 2008. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism - the GENOBIN study. PLOS ONE [ONLINE] 3 7: e2630. 2008

Tolppanen A-M, Pulkkinen L, Kuulasmaa T, Kolehmainen M, Schwab U, Lindström J, Tuomilehto J, Uusitupa M, Kuusisto J. 2008. The genetic variation in the tenomodulin gene is associated with serum total and LDL cholesterol in a body size-dependent manner. INTERNATIONAL JOURNAL OF OBESITY 32: 1868-1872. 2008

Uusitupa M. 2008. Genetics or lifestyle - How do we prevent diabetes?, European Endocrinolgy. [Online].Touch Briefings. 19-21. 2008

Lappalainen T, Kolehmainen M, Schwab U, Pulkkinen L, Laaksonen DE, Rauramaa R, Uusitupa M, Gylling H. 2008. Serum concentrations and expressions of serum amyloid A and leptin in adipose tissue are interrelated: the Genobin Study. EUROPEAN JOURNAL OF ENDOCRINOLOGY 158 3: 333-341. 2008

Laaksonen DE, Niskanen L, Mykkänen H, Juntunen KS, Schwab U, Kolehmainen M, Rauramaa R, Tuomilehto J, Uusitupa M, Kolehmainen M, Uusitupa M. 2008. Long-term repeatability of measures of early insulin secretion derived from an intravenous glucose tolerance test and conversion from impaired glucose tolerance to diabetes. Annals of Medicine 40: 303-311. 2008

Kolehmainen M, Salopuro T, Schwab US, Kekäläinen J, Kallio P, Laaksonen DE, Pulkkinen L, Lindi VI, Sivenius K, Mager U, Siitonen N, Niskanen L, Gylling H, Rauramaa R, Uusitupa M, Kolehmainen M, Salopuro T, Schwab US, Kallio P, Pulkkinen L, Lindi VI. 2008. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. INTERNATIONAL JOURNAL OF OBESITY 32 2: 292-303. 2008

Fagerholm Rainer, Hofstetter Barbara, Tommiska Johanna, Aaltonen Kirsimari, Vrtel Radek, Syrjäkoski Kirsi, Kallioniemi Anne, Kilpivaara Outi, Mannermaa Arto, Kosma Veli-Matti, Uusitupa Matti, Eskelinen Matti, Kataja Vesa, Aittomäki Kristiina. 2008. NAD(P)H:quinone oxidoreductase 1 NQ01*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. NATURE GENETICS 40 7: 844-853. 2008

De Mello V, Kolehmainen M, Pulkkinen L, Schwab U, Mager U, Laaksonen DE, Niskanen L, Gylling H, Atalay M, Rauramaa R, Uusitupa M, De Mello V, Kolehmainen M, Pulkkinen L, Schwab U, Mager U, Gylling H, Uusitupa M. 2008. Downregulation of genes involved in NFkappaB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study. DIABETOLOGIA 51: 2060-2067. 2008

Kilpeläinen TO, Lakka TA, Laaksonen DE, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Lindi V, Tuomilehto J, Uusitupa M, Laakso M. 2008. SNPs in PPARG associte with type 2 diabetes and intract with physival activity. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE 40: 25-33. 2008

Erkkilä AT, Schwab US, De Mello VDF, Lappalainen T, Mussalo H, Lehto S, Kemi V, Lamberg-Allardt C, Uusitupa MIJ. 2008. Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications. EUROPEAN JOURNAL OF NUTRITION 47 6: 319-328. 2008

de Mello VDF, Kolehmainen M, Schwab U, Mager U, Laaksonen DE, Pulkkinen L, Niskanen L, Gylling H, Atalay M, Rauramaa R, Uusitupa M, Ferreira de Mello V, Kolehmainen M, Schwab U, Mager U, Pulkkinen L, Gylling H, Uusitupa M. 2008. Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome. METABOLISM: CLINICAL AND EXPERIMENTAL 57: 192-199. 2008

Garcia-Closas M, Hall P, Nevanlinna H ..., Mannermaa A, Uusitupa M, Eskelinen M, Tengström M, Kosma V-M, Kataja V, Chenevix-Trench G .... 2008. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLOS GENETICS [ONLINE) 4 4: [e1000054]. 2008

Ilanne-Parikka P, Eriksson JG, Lindström J , Peltonen M, Aunola S, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M, Valle TT, Lahtela J, Uusitupa M, Tuomilehto J, on behalf of the Finnish Diabetes Prevention Study Group. 2008. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish diabetes prevention study. DIABETES CARE 31 4: 805-807. 2008

Kallio P, Kolehmainen M, Laaksonen DE, Pulkkinen L, Atalay M, Mykkänen H, Uusitupa M, Poutanen K, Niskanen L, Kallio P, Kolehmainen M, Pulkkinen L, Mykkänen H, Uusitupa M, Poutanen K. 2008. Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individulas with the metabolic syndrome1-3. AMERICAN JOURNAL OF CLINICAL NUTRITION 87: 1497-503. 2008

Kilpeläinen TO, Lakka TA, Laakosnen DE, Mager U, Salopuro T, Kubaszek A, Todorova B, Laukkanen O, Lindström J, Eriksson JG, Hämäläinen H, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M. 2008. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome. The Finnish Diabetes Prevention Study. METABOLISM: CLINICAL AND EXPERIMENTAL 57: 428-436. 2008

Wang J, Kuusisto J, Vänttinen M, Kuulasmaa T, Lindström J, Tuomilehto J, Uusitupa M, Laakso M, Laakso M. 2007. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. DIABETOLOGIA 50: 1192-1200. 2007

Uusitupa M. 2007. Kansantaudit, ravitsemus ja perimä. BOLUS : RAVITSEMUSTERAPEUTTIEN YHDISTYKSEN LEHTI 2: 12-14. 2007

Tolppanen AM, Pulkkinen L, Kolehmainen M, Schwab U, Lindström J, Tuomilehto J, Uusitupa M. 2007. Tenomodulin is associated with obesity and diabetes risk: the Finnish diabetes prevention study. OBESITY (SILVER SPRING, MD.) 15 5: 1082. 2007

Sillanpää P, Heikinheimo L, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H, Metsola K, Hirvonen A. 2007. CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish caucasian population. BREAST CANCER RESEARCH AND TREATMENT 104: 287-297. 2007

Ottelin A-M, Lindström J, Peltonen M, Martikainen J, Uusitupa M, Gylling H, Poutanen K, Louheranta A, Mannelin M, Paturi M, Salminen V, Tuomilehto J, Ottelin A-M, Uusitupa M, Gylling H, Poutanen K. 2007. Costs of a self-selected, health-promoting diet among the participants of the Finnish Diabetes Prevention Study. DIABETES CARE 30 5: 1275-1277. 2007

Lindgren P, Lindström J, Tuomilehto J, Uusitupa M, Peltonen M, Jönsson B, De Faire U, Hellénius M-L, The DPS Study Group. 2007. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 23: 177-183. 2007

Laaksonen DE, Lindström J, Tuomilehto J, Uusitupa M. 2007. Increased physical activity is a cornerstone in the prevention of type 2 diabetes in high-risk individuals. DIABETOLOGIA 50: 2607-2608. 2007

Laaksonen D, Siitonen N, Lindström J, Eriksson JG, Reunanen P, Tuomilehto J, Uusitupa M, for Finnish Diabetes Prevention Study Group. 2007. Physical activity, diet, and incident diabetes in relation to an ADRA2B polymorphism. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE 39: 227-232. 2007

Laakso M, Uusitupa M. 2007. Tyypin 2 diabeteksen ehkäisy. DUODECIM 123: 1439-1447. 2007

Kilpeläinen TO, Lakka TA, Laaksonen DE, Laukkanen O, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M, for the Finnish Diabetes Prevention Study Group, Laakso M. 2007. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. PHYSIOLOGICAL GENOMICS (PRINTED AND ONLINE) 31: 264-272. 2007

Kemppainen T, Janatuinen E, Holm K, Kosma V-M, Heikkinen M, Mäki M, Laurila K, Uusitupa M, Julkunen R. 2007. No observed local immunological response at cell level after five years of oats in adult coeliac disease. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 42: 54-59. 2007

Kallio P, Kolehmainen M, Laaksonen DE, Kekäläinen J, Salopuro T, Sivenius K, Pulkkinen L, Mykkänen HM, Niskanen L, Uusitupa M, Poutanen KS, Kallio P, Kolehmainen M, Salopuro T, Pulkkinen L, Mykkänen HM, Uusitupa M, Poutanen KS. 2007. Hiilihydraattien laatu säätelee geenien ilmentymistä rasvakudoksessa. DUODECIM 123: 1143-1144. 2007

Kallio P, Kolehmainen M, Laaksonen DE, Kekäläinen J, Salopuro T, Sivenius K, Pulkkinen L, Mykkänen HM, Niskanen L, Uusitupa M, Poutanen KS, Kallio P, Kolehmainen M, Poutanen KS. 2007. Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons weith the metabolic syndrome: the FUNGENUT study1-4. AMERICAN JOURNAL OF CLINICAL NUTRITION 85: 1417-1427. 2007

Hallikainen M, Kolehmainen M, Schwab U, Laaksonen DE, Niskanen L, Rauramaa R, Pihlajamäki J, Uusitupa M, Miettinen TA, Gylling H, Kolehmainen M. 2007. Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome. CLINICA CHIMICA ACTA (AMSTERDAM) 383: 126-132. 2007

Giacco R, Cuomo V, Vessby B, Uusitupa M, Hermansen K, Meyer BJ, Riccardi G, Rivellese AA, KANWU study group. 2007. Fish oil, insulin sensitivity, insulin secretion and glucose toleranse in healthy people: Is there any effect of fish oil supplementation in relation to the type of backround diet and habitual dietary intake of n-6 and n-3 fatty acids?. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 17: 572-580. 2007

Erkkilä AT, Schwab US, Ågren JJ, Hallikainen M, Gylling H, Uusitupa MIJ, Schwab US, Uusitupa MIJ. 2007. Moderate increase in dietary sucrose does not influence fasting or postprandial serum lipids regardless of the presence of apolipoprotein E2 allele in healthy subjects EUROPEAN JOURNAL OF CLINICAL NUTRITION 61: 1094-1101. 2007

Uusitupa M. 2006. Perimä ja lihavuus: Mustajoki P. Fogelholm M, Rissanen A, Uusitupa M, Lihavuus. Ongelma ja hoito. 3. uud. p..Duodecim. 86-99. 2006

Uusitupa M. 2006. Lihavuus ja terveys: Mustajoki P. Fogelholm M, Rissanen A, Uusitupa M, Lihavuus. Ongelma ja hoito. 3. uud. p..Duodecim. 25-38. 2006

Uusitupa M. 2006. Ketkä tarvitsevat vitamiinejä?. SUOMEN LÄÄKÄRILEHTI 61: 4451. 2006

Uusitupa M, Tuomilehto J. 2006. Tyypin 2 diabetes on ehkäistävissä ja niksit ovat tiedossa. DUODECIM 122: 2675-2676. 2006

Siitonen N, Pulkkinen L, Mager U, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M, for the Finnish diabetes prevention study group, Siitonen N, Pulkkinen L, Mager U. 2006. Association of sequence variations in the gene encoding adoponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish diabetes prevention study DIABETOLOGIA 49: 1795-1805. 2006

Schwab US, Callaway JC, Erkkilä AT, Gynther J, Uusitupa MIJ, Järvinen T. 2006. Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors EUROPEAN JOURNAL OF NUTRITION 45 8: 470-477. 2006

Schwab U, Törrönen A, Meririnne E, Saarinen M, Alfthan G, Aro A, Uusitupa M. 2006. Orally administered betaine has an acute and dose-dependent effect on serum betaine and plasma homocysteine concentrations in healthy humans. JOURNAL OF NUTRITION 136: 34-38. 2006

Schwab U, Louheranta A, Törrrönen A, Uusitupa M. 2006. Impact of sugar beet pectin and polydextrose on fasting and postprandial glycemia and fasting concentrations of serum total and lipoprotein lipids in middle-aged subjects with abnormal glucose metabolism. EUROPEAN JOURNAL OF CLINICAL NUTRITION 60: 1073-1080. 2006

Rasmussen BM, Vessby B, Uusitupa M, Berglund L, Pedersen E, Riccardi G, Rivellese AA, Tapsell L, Hermandsen K, for the KANWU Study Group. 2006. Effects of dietary saturared, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects 1-3. AMERICAN JOURNAL OF CLINICAL NUTRITION 83: 221-226. 2006

Nälsén C, Vessby B, Berglund L, Uusitupa M, Hermansen K, Riccardi G, Rivellese A, Storlien L, Erkkilä A, Ylä-Herttuala S, Tapsell L, Basu S. 2006. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alfa in healthy humans. JOURNAL OF NUTRITION 136: 1222-1228. 2006

Mustajoki P, Rissanen A, Uusitupa M. 2006. Lihavan potilaan tutkiminen ja hoitomuodon valinta. Teoksessa: Mustajoki P. Fogelholm M, Rissanen A, Uusitupa M (toim.), Lihavuus. Ongelma ja hoito. 3. uud. p..Duodecim. ss. 158-166. 2006

Mager U, Lindi V, Lindström J, Eriksson JG, Vallet TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Pulkkinen L, Uusitupa M, for the Finnish diabetes prevention study group, Mager U, Lindi V, Pulkkinen L. 2006. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of type 2 diabetes in subjects with impaired glucose tolerance in the Finnish diabetes prevention study DIABETIC MEDICINE 23: 685-689. 2006

Mager U, Kolehmainen M, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto JO, Pulkkinen L, Uusitupa MI, for the Finnish diabetes prevention study group, Mager U, Kolehmainen M, Pulkkinen L. 2006. Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance. AMERICAN JOURNAL OF HYPERTENSION 19: 920-926. 2006

Lindström J, Peltonen M, Eriksson JG, Louheranta A, Fogelholm M, Uusitupa M, Tuomilehto J. 2006. High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish diabetes prevention study. DIABETOLOGIA 49: 912-920. 2006

Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Erikssom JG, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J. 2006. Sustained reductione in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish diabetes prevention study. LANCET 368: 1673-1679. 2006

Kolehmainen M, Uusitupa M. 2006. Rasvakudos - aineenvaihdunta ja merkitys lihavuudessa: Mustajoki P. Fogelholm M, Rissanen A, Uusitupa M, Lihavuus. Ongelma ja hoito. 3. uud. p..Duodecim. 62-70. 2006

Herder C, Peltonen M, Koenig W, Kräft I, Mûller-Scholze S, Martin S, Lakka T, Ilanne-Parikka P, Eriksson JG, Hämäläinen H, Keinänen-Kiukaanniemi S, Valle TT, Uusitupa M, Lindström J, Kolb H, Tuomilehto J. 2006. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes. Results from the Finnish diabes prevention study. DIABETES (NY) 55: 2340-2346. 2006

Hartikainen JM, Tuhkanen H, Kataja V, Eskelinen M, Uusitupa M, Kosma V-M, Mannermaa A. 2006. Refinement of the 22q12-q13 Breast Cancer-Associated Region:Evidence of TMPRSS6 as a Candidate in an Eastern Finnish Population CLINICAL CANCER RESEARCH 12 5: 1454-1462. 2006

Niskanen L, Laaksonen DE, Lindström J, Eriksson JG, Keinänen-Kiukaanniemi S, Ilanne-Parikka P, Aunola S, Hämäläinen H, Tuomilehto J, Uusitupa M, for the Finnish Diabetes Prevention Study Group. 2006. Serum uric acid as a harbinder of metabolic outcome in subjects with impaired glucose tolerance. DIABETES CARE 29: 709-711. 2006

Uusitupa M, Uusitupa M. 2005. Sokeri ja diabetes - onko syytä kiristää suitsia?. SUOMEN LÄÄKÄRILEHTI 60 14: 1557-1558. 2005

Uusitupa M, Fogelholm M. 2005. Ravitsemustilan arviointi: Aro A, Mutanen M, Uusitupa M, Ravitsemustiede. 2. uud. p..Duodecim. 291-296. 2005

Sillanpää P, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A. 2005. Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. PHARMACOGENETICS AND GENOMICS 15: 749-752. 2005

Uusitupa M, Uusitupa M. 2005. Gene-diet interaction in relation to the prevention of obesity and type 2 diabetes: Evidence from the Finish diabetes prevention study. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 15: 225-233. 2005

Vauhkonen I, Niskanen L, Knip M, Moilanen Mykkänen L, Uusitupa M, Laakso M. 2005. Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults. EUROPEAN JOURNAL OF ENDOCRINOLOGY 153: 265-273. 2005

Uusitupa M. 2005. Lihavuus. Teoksessa: Aro A, Mutanen M, Uusitupa M (toim.), Ravitsemustiede. 2. uud. p..Duodecim. ss. 369-393. 2005

Uusitupa M. 2005. Liikunta, energiankulutus ja ravitsemus: Vuori I, Taimela S, Kujala U, Liikuntalääketiede. 3. uud. p..Duodecim. 60-75. 2005

Uusitupa M. 2005. Muuttaako lihavuusepidemia kansanterveytemme kehityssuunnan. ELINTARVIKE JA TERVEYS 4-5: 22-24. 2005

Uusitupa M. 2005. Ravitsemus ja diabetes. Teoksessa: Aro A, Mutanen M, Uusitupa M (toim.), Ravitsemustiede. 2. uud. p..Duodecim. ss. 394-424. 2005

Uusitupa M, Fogelholm M. 2005. Antropometriset mittaukset: Aro A, Mutanen M, Uusitupa M, Ravitsemustiede. 2. uud. p..Duodecim. 276-281. 2005

Laukkanen O, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M, Laakso M. 2005. Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversation from impaired glucose tolerance to type 2 diabetes.The Finnish diabetes prevention study. DIABETES (NY) 54: 2256-2260. 2005

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H, Mitrunen K. 2005. NAT2 slow acetylator genotype as an important modifier of breast cancer risk. INTERNATIONAL JOURNAL OF CANCER 114: 579-584. 2005

Hämäläinen H, Rönnemaa T, Virtanen A, Lindström J, Eriksson JG, Valle TT, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Rastas M, Aunola S, Uusitupa M, TuomilehtoJ, on behalf of the Finnish Diabetes Prevention Study Group. 2005. Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish diabetes prevention study. DIABETOLOGIA 48: 2248-2253. 2005

Salopuro T, Pulkkinen L, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M, for the Finnish Diabetes Prevention Study Group, Salopuro T, Pulkkinen L, Uusitupa M, Laakso M. 2005. Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish diabetes prevention study. INTERNATIONAL JOURNAL OF OBESITY 29: 1245-1251. 2005

Fogelholm M, Uusitupa M. 2005. Kehon koostumuksen arviointi: Aro A, Mutanen M, Uusitupa M, Ravitsemustiede. 2. uud. p..Duodecim. 282-290. 2005

Hartikainen JM, Tuhkanen H, Kataja V, Dunning AM, Antoniou A, Smith P, Arffman A, Pirskanen M, Easton DF, Eskelinen M, Uusitupa M, Kosma V-M, Mannermaa A. 2005. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in Eastern Finland: three candidate regions found. CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION 14 1: 75-80. 2005

Erkkilä AT, Närvänen O, Lehto S, Uusitupa MIJ, Ylä-Herttuala S. 2005. Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease. ATHEROSCLEROSIS 183: 157-162. 2005

Kolehmainen M, Poutanen K, Uusitupa M, Poutanen K. 2005. Nutrigenomiikka - avain ravintotekijöiden molekulaaristen vaikutusten selvittämiseen. Ravinnon ja perintötekijöiden yhteisvaikutusten salat julki. DUODECIM 121: 2139-2141. 2005

Laaksonen DE, Lindström J, Lakka TA, Eriksson JG, Niskanen L, Wikström K, Aunola S, Keinänen-Kiukaanniemi S, Laakso M, Valle TT, Ilanne-Parikka P, Louheranta A, Hakumäki M, Kaikkonen H, Härkönen P, Sundvall J, Tuomilehto J, Uusitupa M, Louheranta A. 2005. Physical activity in the prevention of type 2 diabetes. The Finnish diabetes prevention study. DIABETES (NY) 54: 158-165. 2005

Laitinen J, Uusitupa M. 2005. Nuorten nopea lihominen hätkähdyttää. SUOMEN LÄÄKÄRILEHTI 60 42: 4227. 2005

Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, Kosma V-M, Uusitupa M, Hirvonen A. 2005. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in the Finnish case-control study. BREAST CANCER RESEARCH [ONLINE: HTTP://BREAST-CANCER-RESEARCH.COM/] 7: R987-R997. 2005

Sivenius K, Pihlajamäki J, Partanen J, Niskanen L, Laakso M, Uusitupa M. 2004. Aldose reductase gene polymorphisms and peripheral nerve function in patients with type 2 diabetes. DIABETES CARE 27: 2021-2026. 2004

Yliharsila H, Eriksson JG, Forsen T, Laakso M, Uusitupa M, Osmond C, Barker DJ, Laakso M. 2004. Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication. JOURNAL OF HYPERTENSION 22 7: 1283-1287. 2004

Vaccaro O, Masulli M, Vincenzo C, Rivellese AA, Uusitupa M, Vessby B, Hermansen K, Tapsell L, Riccardi G. 2004. Comparative evaluation of simple indices of insulin resistance. METABOLISM: CLINICAL AND EXPERIMENTAL 53: 1522-1526. 2004

Uusitupa M. 2004. Ravitsemus- ja liikuntasuositukset linjaavat tervytemme perustan. SUOMEN LÄÄKÄRILEHTI 59: 4963. 2004

Uusitupa M. 2004. Perinnöllisen kombinoituneen hyperlipidemian (FKH) geneettinen tausta - rengas kiristyy. DUODECIM 120: 1193-1194. 2004

Uusitupa M, Lindi V, Louheranta A, Salopuro T, Lindström J, Tuomilehto J, Salopuro T. 2004. Elämäntapamuutokset korjaavat pysyvästi insuliiniresistenssia heikentyneessä sokerinsiedossa. DUODECIM 120: 1495-1497. 2004

Todorova B, Kubaszek A, Pihlajamäki J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M, Laakso M. 2004. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 89 5: 2019-2023. 2004

Tapola NS, Lyyra ML, Karvonen HM, Uusitupa MI, Sarkkinen ES. 2004. The effect of meat products enriched with plant sterols and minerals on serum lipids and blood pressure. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION 55: 389-397. 2004

Suomen Sisätautilääkärien Yhdistys ry:n asettama työryhmä, Gylling H, Uusitupa M, Laakso M. 2004. Dyslipidemiat. DUODECIM 120: 1794-1816. 2004

Sivenius K, Niskanen L, Voutilainen-Kaunisto R, Laakso M, Uusitupa M. 2004. Aldose reductase gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. DIABETIC MEDICINE 21: 1325-1333. 2004

Heikkinen A-M, Niskanen LK, Salmi JA, Koulu M, Pesonen U, Uusitupa MIJ, Komulainen MH, Tuppurainen MT, Kröger H, Jurvelin J, Saarikoski S, Kröger H. 2004. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women BONE 35: 589-594. 2004

Siitonen N, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M. 2004. Association between a deletion/insertion polymorphism in the alfa2B-adrenergic receptor gene and insulin secretion and type 2 diabetes. The Finnish diabetes prevention study DIABETOLOGIA 47: 1416-1424. 2004

Salopuro T, Lindström J, Eriksson JG, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M, Finnish Diabetes Preventio Study Group. 2004. Common variants in beta2- and beta3-adrenergic receptor genes and uncoupling protein 1 as predictors of the risk for type 2 diabetes and body weight changes. The Finnish diabetes prevention study CLINICAL GENETICS (COPENHAGEN) 66: 365-367. 2004

Martikainen T, Pirinen E, Alhava E, Poikolainen E, Pääkkönen M, Uusitupa M, Gylling H. 2004. Long-term results, late complications and quality of life in a series of adjustable gastric banding. OBESITY SURGERY 14: 648-654. 2004

Mann JI, De Leeuw I, Hermansen K, Karamanos B, Karlström B, Katsilamros N, Riccardi G, Rivellese AA, Rizkalla S, Slama G, Toeller M, Uusitupa M, Vessby B, on behalf of the (DNSG) of the (EASD). 2004. Evidence-based nutritional approaches to treatment and prevention of diabetes mellitus. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 14: 373-394. 2004

Laukkanen O, Pihlajamäki J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M, for the Finnish diabetes prevention study group. 2004. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish diabetes prevention study. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 89: 6286-6290. 2004

Laukkanen O, Pihlajamäki J, Lindström J, Eriksson J, Valle TT, Hämaläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M, for the Finnish Diabetes Prevention Study Group, Laakso M. 2004. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes DIABETOLOGIA 47: 871-877. 2004

Laaksonen DE, Niskanen L, Lakka H-M, Lakka TA, Uusitupa M, Laaksonen DE. 2004. Epidemiology and treatment of the metabolic syndrome. Annals of Medicine 36: 332-346. 2004

Ilanne-Parikka P, Eriksson JG, Lindström J, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Rastas M, Salminen V, Aunola S, Sundvall J, Valle T, Lahtela J, Uusitupa M, Tuomilehto J. 2004. Prevalence of the metabolic syndrome and its components. Finding from a Finnish general population sample and the diabetes prevention study cohort DIABETES CARE 27: 2135-2140. 2004

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H, Mitrunen K. 2004. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. PHARMACOGENETICS AND GENOMICS 14: 239-245. 2004

Uusitupa M, Lindi V, Louheranta A, Salopuro T, Lindström J, Tuomilehto J, for the Finnish Diabetes Prevention Study Group. 2003. Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance.4-year results from the Finnish diabetes prevention study. DIABETES (NY) 52: 2532-2538. 2003

Rivellese AA, Maffettone A, Vessby B, Uusitupa M, Hermansen K, Berglund L, Louheranta A, Meyer BJ, Riccardi G. 2003. Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. ATHEROSCLEROSIS 167: 149-158. 2003

Sivenius K, Niskanen L, Laakso M, Uusitupa M, Laakso M. 2003. A deletion in the alfa2B-adrenergic receptor gene and autonomic nervous function in central obesity. OBESITY (SILVER SPRING, MD.) 11: 962-970. 2003

Tammela LI, Rissanen A, Kuikka JT, Karhunen LJ, Bergström KA, Repo-Tiihonen E, Naukkarinen H, Vanninen E, Tiihonen J, Uusitupa M. 2003. Treatment improves serotonin transporter binding and reduces binge eating. PSYCHOPHARMACOLOGY 170: 89-93. 2003

Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J, for the Finnish Diabetes Prevention Study Group. 2003. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. DIABETES CARE 26: 3230-3236. 2003

Uusitupa M. 2003. Aineenvaihdunnan ja ravitsemuksen häiriöt: Koskenvuo K, Sairauksien ehkäisy. 2. uud. p..Duodecim. 208-215. 2003

Uusitupa M. 2003. Diabetes: Koskenvuo K, Sairauksien ehkäisy. 2. uud. p..Duodecim. 216-225. 2003

Uusitupa M. 2003. Intressiristiriidat lääketieteelisen tutkimuksen rahoituksessa.Yhteisillä pelisäännöillä ongelmat vähenevät DUODECIM 119: 1405-1407. 2003

Uusitupa M. 2003. Uudistuuko psykiatria terveydenhuollossa. Teoksessa: Valkonen-Korhonen M, Lehtonen K, Tuovinen T (toim.), Mielenterveys uusiutuvana voimavarana.Helsinki University Press . ss. 272-276. 2003

Niskanen L, Lindi V, Erkkilä A, Sivenius K, Luoma J, Ylä-Herttuala S, Laakso M, Uusitupa MIJ, Laakso M. 2003. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects. METABOLISM: CLINICAL AND EXPERIMENTAL 52 2: 213-217. 2003

Pihlajamäki J, Karhapää P, Vauhkonen I, Kekäläinen P, Kareinen A, Viitanen L, Pesonen U, Kallio J, Uusitupa M, Laakso M. 2003. The Leu7Pro polymorphism of the neuropeptide Y gene regulates free fatty acid metabolism. METABOLISM: CLINICAL AND EXPERIMENTAL 52 5: 643-646. 2003

Lindström J, Eriksson JG, Valle TT, Aunola S, Cepaitis Z, Hakumäki M, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Martikkala V, Moltchanov V, Rastas M, Salminen V, Sundvall J, Uusitupa M, Tuomilehto J. 2003. Prevention of diabetes mellitus in subjects with impaired glucpse tolerance in the Finnish diabetes prevention study: Results from a randomized clinical trial. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. SUPPLEMENT 14: S108-S113. 2003

Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R, for the Stresa Workshop participants, Gylling H, Uusitupa M. 2003. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. MAYO CLINICAL PROCEEDINGS 78: 965-978. 2003

Lindi V, Schwab U, Louheranta A, Laakso M, Vessby B, Hermansen K, Storlien L, Riccardi G, Rivellese AA, Uusitupa MIJ, for the KANWU Study Group, Laakso M. 2003. Impact of the pro12ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n - 3 fatty acid supplementation. For the KANWU study group MOLECULAR GENETICS AND METABOLISM (ARLANDO) 79: 52-60. 2003

Erkkilä AT, Lehto S, Pyörälä K, Uusitupa MIJ. 2003. n-3 fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease1-3. AMERICAN JOURNAL OF CLINICAL NUTRITION 78: 65-71. 2003

Järvinen RMK, Loukaskorpi M, Uusitupa MIJ. 2003. Tolerance of symptomatic lactose malabsobers to lactose in milk chocolate. EUROPEAN JOURNAL OF CLINICAL NUTRITION 57: 701-705. 2003

Karhunen L, Kuikka JT, Uusitupa M. 2003. Aivojen kuvantaminen syömishäiriöiden ja lihavuuden tutkimuksessa DUODECIM 119: 859-865. 2003

Eriksson JG, Osmond C, Lindi V, Uusitupa M, Forsen T, Laakso M, Barker D, Laakso M. 2003. Interactions between peroxisome proliferator-activated receptor gene polymorphism and birth length influence risk for type 2 diabetes. DIABETES CARE 26: 2476--2477. 2003

Kolehmainen M, Uusitupa MIJ, Alhava E, Laakso M, Vidal H, Laakso M. 2003. Effect of the pro12ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 88 4: 1717-1722. 2003

Korhonen M, Kastarinen M, Uusitupa M, Puska P, Nissinen A. 2003. The effect of intensified diet conseling on the diet of hypertensive subjects in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland. PREVENTIVE MEDICINE 36: 8-16. 2003

Kubaszek A, Pihlajamäki J, Komarovski V, Lindi V, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M, Laakso M. 2003. Promoter polymorphisms of the TNF-alfa (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. DIABETES (NY) 52: 1872-1876. 2003

Eriksson J, Lindi V, Uusitupa M, Forsén T, Laakso M, Osmond C, Barker D, Laakso M. 2003. The effects of the Pro12Ala polymorphism of the PPARgamma-2 gene on lipid metabolism interact with body size at birth. CLINICAL GENETICS (COPENHAGEN) 64: 366-370. 2003

Laitinen T, Vauhkonen I, Niskanen L, Hartikainen J, Uusitupa M, Laakso M. 2003. Prolonged corrected QT interval is associated with acute and chronic hyperinsulinemia in nondiabetic subjects. DIABETES CARE 26 8: 2480-2481. 2003

Voutilainen-Kaunisto R, Niskanen L, Uusitupa M, Teräsvirta M. 2002. Iris transluminance in type 2 diabetes. ACTA OPHTHALMOLOGICA 80: 64-68. 2002

Valle TT, Lindström J, Eriksson JG, Hämäläinen H, Parikka P-I, Keinänen-Kiukaanniemi S, Louheranta A, Laakso M, Martikkala V, Rastas M, Salminen V, Aunola S, Hakumäki M, Mannelin M, Sundvall J, Uusitupa M, Tuomilehto J. 2002. Elämäntapamuutokset tehokkaita tyypin 2 diabeteksen ehkäisyssä. Diabetes prevention study, DPS SUOMEN LÄÄKÄRILEHTI 57: 1369-1377. 2002

Uusitupa M. 2002. Lifestyles matter in the prevention of type 2 diabetes DIABETES CARE 25: 1650-1651. 2002

Uusitupa M. 2002. Lifestyle intervention in the prevention of type 2 diabetes. DIABETES AND RELATED DISORDERS 9: 3-4. 2002

Schwab US, Ågren JJ, Valve R, Hallikainen MA, Sarkkinen ES, Jauhiainen M, Karvonen MK, Pesonen U, Koulu M, Uusitupa MIJ, Savolainen MJ. 2002. The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprantial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet EUROPEAN JOURNAL OF CLINICAL NUTRITION 56: 149-156. 2002

Schwab U, Törrönen A, Toppinen L, Alftan G, Saarinen M, Aro A, Uusitupa M. 2002. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjets 1,2,3. AMERICAN JOURNAL OF CLINICAL NUTRITION 76: 961-967. 2002

Rissanen A, Uusitupa M. 2002. Lihavuus ja ahmimishäiriö. Teoksessa: Neuvonen PJ , Himberg J-J, Huupponen R, Kivistö KT, Ylitalo P (toim.), Kliininen farmakologia ja lääkehoito.Kandidaattikustannus. ss. 428-434. 2002

Mitrunen K, Kataja V, Eskelinen M, Kosma V-M, Kang D, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. 2002. Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. PHARMACOGENETICS AND GENOMICS 12: 67-72. 2002

Louheranta AM, Sarkkinen ES, Vidgren HM, Schwab US, Uusitupa MIJ. 2002. Association of the fatty acid profile of serum lipids with glucose and insulin metabolism during 2 fat-modified diets in subjects with impaired glucose tolerance 1-3 AMERICAN JOURNAL OF CLINICAL NUTRITION 76: 331-337. 2002

Lindi VI, Uusitupa MIJ, Lindström J, Louheranta A, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Tuomilehto J, for the Finnish Diabetes Prevention Study Group. 2002. Association of the Pro12Ala polymorphism in the PPAR-gamma2 with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. DIABETES (NY) 51: 2581-2586. 2002

Kolehmainen M, Vidal H, Ohisalo JJ, Pirinen E, Alhava E, Uusitupa MIJ. 2002. Hormone sensitive lipase expression and adipose tissue metabolism show gender difference in obese subjects after weight loss. INTERNATIONAL JOURNAL OF OBESITY 26: 6-16. 2002

Kastarinen MJ, Puska PM, Korhonen MH, Mustonen JN, Salomaa VV, Sundvall JE, Tuomilehto JO, Uusitupa MI, Nissinen AM, for the LIHEF Study Group. 2002. Non-pharmacological treatment of hypertension in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland. JOURNAL OF HYPERTENSION 20: 2505-2512. 2002

Karvonen HM, Tapola NS, Uusitupa MI, Sarkkinen ES. 2002. The effect of vegetable oil-based cheese on serum total and lipoprotein lipids EUROPEAN JOURNAL OF CLINICAL NUTRITION 56: 1094-1101. 2002

Janatuinen EK, Kemppainen TA, Julkunen RJK, Kosma V-M, Mäki M, Heikkinen M, Uusitupa MIJ. 2002. No harm from five year ingestion of oats in coeliac disease. GUT 50: 332-335. 2002

Heo M, Leibel RL, Fontaine KR, Boyer BB, Chung WK, Koulu M, Karvonen MK, Pesonen U, Rissanen A, Laakso M, Uusitupa MIJ, Chagnon Y, Bouchard C, Donohoue PA, Burns TL, Shuldiner AR, Silver K, Andersen RE, Pedersen O, Echwald S, Sorensen TIA, Behn P, Permutt MA, Jacobs KB, Elston RC, Hoffman DJ, Gropp E, Allison DB. 2002. A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index an waist circumference INTERNATIONAL JOURNAL OF OBESITY 26: 640-646. 2002

Hendolin M, Uusitupa M. 2002. Ravintotekijät säätelevät geenien toimintaa. KEHITTYVÄ ELINTARVIKE 2: 6-7. 2002

Hallikainen M, Sarkkinen E, Wester I, Uusitupa M. 2002. Short-term LDL cholesterol-lowering efficacy of plant stanol esters BMC CARDIOVASCULAR DISORDERS [ONLINE: HTTP://WWW.BIOMEDCENTRAL.COM/1471-2261/] 2: 1-14. 2002

Haapala I, Hirvonen A, Niskanen L, Uusitupa M, Kröger H, Alhava E, Nissinen A. 2002. Anthropometry, bioelectrical impedance and dual-energy X-ray absorptiometry in the assessment of body composition in elderly Finnish women. CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING 22: 383-391. 2002

Erkkilä AT, Lindi V, Lehto S, Pyörälä K, Laakso M, Uusitupa MIJ. 2002. Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 12: 53-59. 2002

Erkkilä AT, Lindi V, Lehto S, Laakso M, Uusitupa MIJ. 2002. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. MOLECULAR GENETICS AND METABOLISM (ARLANDO) 75: 260-264. 2002

Erkkilä A, Uusitupa M. 2002. N-3-sarjan rasvahapot suojaavat sepelvaltimotautipotilasta äkkikuolemalta DUODECIM 118: 1631-1632. 2002

Eriksson JG, Lindi V, Uusitupa M, Forsén TJ, Laakso M, Osmond C, Barker DJP. 2002. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. DIABETES (NY) 51: 2321-2324. 2002

Karvonen HM, Aro A, Tapola NS, Salminen I, Uusitupa MIJ, Sarkkinen ES. 2002. Effect of alfa-linolenic acid-rich camelina sativa oil on serum fatty acid composition and serum lipids in hypercholesterolemic subjects METABOLISM: CLINICAL AND EXPERIMENTAL 51: 1253-1260. 2002

Uusitupa M. 2001. Liikunta ja ruokavalio ovat metabolisen oireyhtymän täsmähoitoa. DUODECIM 117: 621-630. 2001

Sivenius K, Lindi V, Niskanen L, Laakso M, Uusitupa M. 2001. Effect of a three-amino acid deletion in the alfa2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects. INTERNATIONAL JOURNAL OF OBESITY 25: 1609-1614. 2001

Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, for the Finnish Diabetes Prevention Study Group, Hakumäki M. 2001. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEW ENGLAND JOURNAL OF MEDICINE 344: 1343-1350. 2001

Uusitupa M, Tuomainen R. 2001. Yhteistyö sairaanhoitopiirien välillä Suomessa. SUOMEN LÄÄKÄRILEHTI 56 6: 683-687. 2001

Uusitupa M. 2001. Aikuistyypin diabeteksen ehkäisy - haaste terveydenhuollollemme. DIABETES JA LÄÄKÄRI 30 : 6-7. 2001

Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H. 2001. Serum enterolactone and risk of breast cancer: A case-control study in Eastern Finland. CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION 10: 339-344. 2001

Valle TT, Lindström J, Eriksson JG, Uusitupa M, Tuomilehto J. 2001. Tyypin 2 diabetes on ehkäistävissä elämäntapamuutoksilla. DUODECIM 117: 1517-1518. 2001

Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nälsén C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson I-B, Storlien LH. 2001. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women:The KANWU study. DIABETOLOGIA 44: 312-319. 2001

Voutilainen-Kaunisto R, Teräsvirta M, Uusitupa M, Niskanen L. 2001. Maculopathy and visual acuity in newly diagnosed type 2 diabetic patients and non-diabetic subjects: A 10-year follow-up study. ACTA OPHTHALMOLOGICA 79 2: 163-168. 2001

Voutilainen-Kaunisto RM, Teräsvirta ME, Uusitupa MIJ, Niskanen LK. 2001. Occurrence and predictors of retinopathy and visual acuity in type 2 diabetic patients and control subjects 10-year follow-up from the diagnosis JOURNAL OF DIABETES AND ITS COMPLICATIONS 15: 24-33. 2001

Ågren JJ, Vidgren HM, Valve RS, Laakso M, Uusitupa MI. 2001. Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene 1,2 AMERICAN JOURNAL OF CLINICAL NUTRITION 73: 31-35. 2001

Rissanen P, Vahtera E, Krusius T, Uusitupa M, Rissanen A. 2001. Weight change and blood coagulability and fibrinolysis in healthy obese women. INTERNATIONAL JOURNAL OF OBESITY 25: 212-218. 2001

Hirvonen A, Bouchardy C, Mitrunen K, Kataja V, Eskelinen M, Kosma V-M, Saarikoski ST, Jourenkova N, Anttila S, Dayer P, Uusitupa M, Benhamou S. 2001. Polymorphic GSTs and cancer predisposition. CHEMICO-BIOLOGICAL INTERACTIONS 133: 75-80. 2001

Mitrunen K, Sillanpää P, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, Uusitupa M, Hirvonen A. 2001. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk CARCINOGENESIS 22 5: 827-829. 2001

Kaukua J, Turpeinen A, Uusitupa M, Niskanen L. 2001. Clustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking. DIABETES, OBESITY AND METABOLISM 3: 17-23. 2001

Erkkilä AT, Sarkkinen ES, Lindi V, Lehto S, Laakso M, Uusitupa MIJ. 2001. APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose 1-3. AMERICAN JOURNAL OF CLINICAL NUTRITION 73: 746-752. 2001

Järvinen R, Uusitupa M. 2001. D-vitamiini ja eturauhassyöpä. SUOMEN LÄÄKÄRILEHTI 56 33: 3211-3212. 2001

Kallio J, Pesonen U, Kaipio K, Karvonen MK, Jaakkola U, Heinonen OJ, Uusitupa MIJ, Koulu M. 2001. Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. FASEB JOURNAL 15: 1242-1244. 2001

Karvonen MK, Valkonen V-P, Lakka TA, Salonen R, Koulu M, Pesonen U, Tuomainen T-P, Kauhanen J, Nyyssönen K, Lakka H-M, Uusitupa MIJ, Salonen JT. 2001. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. ATHEROSCLEROSIS 159: 145-151. 2001

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. 2001. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION 10: 229-236. 2001

Knuuti J, Takala TO, Någren K, Sipilä H, Turpeinen AK, Uusitupa MIJ, Nuutila P. 2001. Myocardial fatty acid oxidation in patients with impaired glucose tolerance. DIABETOLOGIA 44: 184-187. 2001

Kuikka JT, Tammela L, Bergström KA, Karhunen L, Uusitupa M, Tiihonen J. 2001. Effects of ageing on serotonin transporters in healthy females. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 28: 911-913. 2001

Kuikka JT, Tammela L, Karhunen L, Rissanen A, Bergström KA, Naukkarinen H, Vanninen E, Karhu J, Lappalainen R, Repo-Tiihonen E, Tiihonen J, Uusitupa M. 2001. Reduced serotonin transporter binding in binge eating women. PSYCHOPHARMACOLOGY 155: 310-314. 2001

Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MIJ. 2001. Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on lon-term weight change in Finnish non-diabetic subjects. DIABETOLOGIA 44: 925-926. 2001

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, Kang D, Vainio H, Uusitupa M, Hirvonen A. 2001. Polymorphic catechol-O-methyltransferase gene and breast cancer risik. CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION 10: 635-640. 2001

Kolehmainen M, Vidal H, Alhava E, Uusitupa MIJ. 2001. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity OBESITY (SILVER SPRING, MD.) 9: 706-712. 2001

Sivenius K, Valve R, Lindi V, Niskanen L, Laakso M, Uusitupa M. 2000. Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on long-term body weight chance in Finnish type 2 diabetic and non-diabetic control subjects. INTERNATIONAL JOURNAL OF OBESITY 24: 514-519. 2000

Männistö S, Virtanen M, Kataja V, Uusitupa M, Pietinen P. 2000. Lifetime alcohol consumption and breast cancer: a case-control study in Finland PUBLIC HEALTH NUTRITION 3 1: 11-18. 2000

Niskanen L, Karvonen MK, Valve R, Koulu M, Pesonen UM, Mercuri M, Rauramaa R, Töyry J, Laakso M, Uusitupa MIJ. 2000. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 85: 2266-2269. 2000

Niskanen L, Voutilainen-Kaunisto R, Teräsvirta M, Karvonen M K, Valve R, Pesonen U, Laakso M, Uusitupa MIJ, Koulu M. 2000. Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in Type 2 diabetes. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY AND DIABETES 108: 235-236. 2000

Rissanen J, Wang H, Miettinen R, Kärkkäinen P, Kekäläinen P, Mykkänen L, Kuusisto J, Karhapää P, Niskanen L, Uusitupa M, Laakso M. 2000. Variants in the hepatocyte nuclear factor-1alfa and -4alfa genes in Finnish and Chinese subjects with late-onset type 2 diabetes. DIABETES CARE 23: 1533-1538. 2000

Sarkkinen E, Hallikainen M, Uusitupa M. 2000. Stanolia, sterolia - mutta kuinka paljon?. SUOMEN LÄÄKÄRILEHTI 55 8: 846-847. 2000

Sarkkinen E, Uusitupa M. 2000. Onko suklaa terveellistä? SUOMEN LÄÄKÄRILEHTI 55 30: 2902-2903. 2000

Uusitupa M, Louheranta A, Lindström J, Valle T, Sundvall J, Eriksson J, Tuomilehto J, on behalf of the Finnish Diabetes Prevention Study Group. 2000. The Finnish Diabetes Prevention Study. BRITISH JOURNAL OF NUTRITION. SUPPLEMENT 83 1: S137-S142. 2000

The Diabetes and Nutrition Study Group of the EASD, Uusitupa M. 2000. Recommendations for the nutritional management of patients with diabetes mellitus. EUROPEAN JOURNAL OF CLINICAL NUTRITION 54: 353-355. 2000

Turpeinen AK, Kuikka JT, Vanninen E, Yang J, Uusitupa MIJ. 2000. Long-term effect of acetyl-L-carnitine on myocardial 123I-MIBG uptake in patients with diabetes. CLINICAL AUTONOMIC RESEARCH 10: 13-16. 2000

Uusitupa M, Kemppainen T. 2000. Kaura ja keliakia. Pitkäaikaistulokset varmistavat kauran sopivuuden. SUOMEN LÄÄKÄRILEHTI 55 17: 1868-1869. 2000

Uusitupa M. 2000. Sydänmerkki tutuksi. SUOMEN LÄÄKÄRILEHTI 55 16: 1717. 2000

Uusitupa M. 2000. Tieteellinen ja kliininen työ - yhdessä vai erikseen?: Voipio-Pulkki L-M, Grenman R, Haapamäki M, Lenander-Lumikari M, Mäkinen J, Rautava P, Scheinin M, Vainikainen T, Kliinisen tutkijan opas.Duodecim. 27-35. 2000

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. 2000. Steroid metabolism gene CYP17 polymorpsm and the develpment of breast cancer. CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION 9: 1343-1348. 2000

Vauhkonen IKJ, Niskanen LK, Mykkänen L, Haffner SM, Uusitupa MIJ, Laakso M. 2000. Hyperproinsulinemia is not a charascteristic feature in the offspring of patients with different phenotypes of type II diabetes. EUROPEAN JOURNAL OF ENDOCRINOLOGY 143: 251-260. 2000

Voutilainen-Kaunisto RM, Teräsvirta ME, Uusitupa MIJ, Niskanen LK. 2000. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects. DIABETES CARE 23: 1672-1678. 2000

Vauhkonen I, Niskanen L, Knip M, Ilonen J, Vanninen E, Kainulainen S, Uusitupa M, Laakso M. 2000. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults DIABETOLOGIA 43: 69-78. 2000

Männistö S, Alfthan G, Virtanen M, Kataja V, Uusitupa M, Pietinen P. 2000. Toenail selenium and breast cancer - a case-control study in Finland. EUROPEAN JOURNAL OF CLINICAL NUTRITION 54: 98-103. 2000

Louheranta AM, Schwab US, Sarkkinen ES, Voutilainen ET, Ebeling TML, Erkkilä AT, Turpeinen AK, Uusitupa MIJ. 2000. Insulin sensitivity after a reduced-fat diet and a monoene-ecriched idiet in subjects with elevated serum cholesterol and triglyceride concentrations. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 10: 177-187. 2000

Helisalmi S, Valve R, Karvonen MK, Hiltunen M, Pirskanen M, Mannermaa A, Koulu M, Pesonen U, Uusitupa M, Soininen H. 2000. The leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide y is not associated with Alzheimer¿s disease or the link apolipoprotein E. NEUROSCIENCE LETTERS 287: 25-28. 2000

Louheranta A, Uusitupa M. 2000. Aikuistyypin diabeteksen ehkäisy. SUOMEN LÄÄKÄRILEHTI 55 39: 3919-3921. 2000

Collin H-L, Sorsa T, Meurman JH, Niskanen L, Salo T, Rönkä H, Konttinen YT, Koivisto A-M, Uusitupa M. 2000. Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus. JOURNAL OF PERIODONTAL RESEARCH (COPENHAGEN) 35: 259-265. 2000

Erkkilä AT, Närvänen O, Lehto S, Uusitupa MIJ, Ylä-Herttuala S. 2000. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease ARTERIOSCLEROSIS, THROMBOSIS AND VASCULAR BIOLOGY 20: 204-209. 2000

Fogelholm M, Rankinen T, Isokääntä M, Kujala U, Uusitupa M. 2000. Growth, dietary intake, and trace element status in pubescent athletes and schoolchildren. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE 32: 738-746. 2000

Hallikainen M, Sarkkinen E, Uusitupa M. 2000. Health effects of plant stanol esters. FOOD INDUSTRY JOURNAL 3 3: 232-238. 2000

Hallikainen MA, Sarkkinen ES, Gylling H, Erkkilä AT, Uusitupa MIJ. 2000. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on low-fat diet. EUROPEAN JOURNAL OF CLINICAL NUTRITION 54: 715-725. 2000

Hallikainen MA, Sarkkinen ES, Uusitupa MIJ. 2000. Plant stanol esters affect serum cholesterol concentrations of hyperchlesterolemic men and women in a done-dependent manner. JOURNAL OF NUTRITION 130: 767-776. 2000

Collin H-L, Niskanen L, Uusitupa M, Töyry J, Collin P, Koivisto A-M, Viinamäki H, Meurman JH. 2000. Oral symptoms and signs in elderly patients with type 2 diabetes mellitus. A focus on diabetic neuropathy. ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY, ORAL RADIOLOGY AND ENDODONTICS 90: 299-305. 2000

Janatuinen EK, Kemppainen TA, Pikkarainen PH, Holm KH, Kosma V-M, Uusitupa MIJ, Mäki M, Julkunen RJK. 2000. Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. GUT 46: 327-331. 2000

Karhunen LJ, Vanninen EJ, Kuikka JT, Lappalainen RI, Tiihonen J, Uusitupa MIJ. 2000. Regional cerebral blood flow during exposure to food in obese binge eating women. PSYCHIATRY RESEARCH: NEUROIMAGING 99: 29-42. 2000

Karvonen MK, Koulu M, Pesonen U, Uusitupa MIJ, Tammi A, Viikari J, Simell O, Rönnemaa T. 2000. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschoolaged children. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 85: 1455-1460. 2000

Kauhanen J, Karvonen MK, Pesonen U, Koulu M, Tuomainen T-P, Uusitupa MIJ, Salonen JT. 2000. Neuropeptide Y polymorphism and alcohol consumption in middle-aged men. AMERICAN JOURNAL OF MEDICAL GENETICS. PART A 93: 117-121. 2000

Kolehmainen M, Ohisalo JJ, Kaartinen JM, Tuononen V, Pääkkönen M, Poikolainen E, Alhava E, Uusitupa MIJ. 2000. Concordance of in vivo microdialysis and in vitro techniques in the studies of adipose tissue metabolism. INTERNATIONAL JOURNAL OF OBESITY 24: 1426-1432. 2000

Korhonen MH, Järvinen RMK, Sarkkinen ES, Uusitupa MIJ. 2000. Effects of a salt-restricted diet on the intake of other nutrients. AMERICAN JOURNAL OF CLINICAL NUTRITION 72: 414-420. 2000

Laaksonen DE, Atalay M, Niskanen LK, Mustonen J, Sen CK, Lakka TA, Uusitupa MIJ. 2000. Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial MEDICINE AND SCIENCE IN SPORTS AND EXERCISE 32: 1541-1548. 2000

Karhunen L, Franssila-Kallunki A, Rissanen P, Valve R, Kolehmainen M, Rissanen A, Uusitupa M. 2000. Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight -reduction programme in obese Finns. INTERNATIONAL JOURNAL OF OBESITY 24: 1567-1572. 2000

Uusitupa M, Fogelholm M. 1999. Antropometriset mittaukset: Aro A, Mutanen M, Uusitupa M, Ravitsemustiede.Duodecim. 267-272. 1999

Louheranta AM, Turpeinen AK, Vidgren HM, Schwab US, Uusitupa MIJ. 1999. A high-trans fatty acid diet and insulin sensitivity in young healthy women METABOLISM: CLINICAL AND EXPERIMENTAL 48 7: 870-875. 1999

Laitinen T, Vauhkonen IKJ, Niskanen LK, Hartikainen JEK, Länsimies EA, Uusitupa MIJ, Laakso M. 1999. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. DIABETES (NY) 48: 1295-1299. 1999

Niskanen L, Uusitupa M, Laakso M. 1999. Hyperglykemian lääkehoito ja aikuistyypin diabeteksen ennuste. DUODECIM 115: 1122-1124. 1999

Romppanen J, Keskikuru R, Kataja V, Eskelinen M, Kosma V-M, Savolainen K, Uusitupa M, Mononen I. 1999. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women BRITISH JOURNAL OF CANCER 79: 1583-1587. 1999

Turpeinen AK, Takala TO, Nuutila P, Axelin T, Luotolahti M, Haaparanta M, Bergman J, Hämäläinen H, Iida H, Mäki M, Uusitupa MIJ, Knuuti J. 1999. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance Studies with PET and 14(R, S)-[18F]Fluoro-6-Thia-Heptadecanoic acid DIABETES (NY) 48: 1245-1250. 1999

Uusitupa M, Fogelholm M, Nuutinen L. 1999. Ravitsemustilan arviointi: Aro A, Mutanen M, Uusitupa M, Ravitsemustiede.Duodecim. 280-285. 1999

Uusitupa M. 1999. Ravitsemus ja diabetes: Aro A, Mutanen M, Uusitupa M, Ravitsemustiede.Duodecim. 377-404. 1999

Uusitupa M, Hallikainen M. 1999. Efficacy of plant stanol esters in subjects consuming NCEP diets. EUROPEAN HEART JOURNAL. SUPPLEMENTS 1: S91-S95. 1999

Uusitupa M. 1999. Lihavuus: Aro A, Mutanen M, Uusitupa M, Ravitsemustiede.Duodecim. 354-376. 1999

Uusitupa M. 1999. New aspects in the management of obesity: operation and the impact of lipase inhibitors. CURRENT OPINION IN LIPIDOLOGY 10: 3-7. 1999

Uusitupa M. 1999. Sydän- ja keuhkosairauksien ravitsemushoito. Teoksessa: Aro A, Mutanen M, Uusitupa M (toim.), Ravitsemustiede.Duodecim. ss. 522-523. 1999

Uusitupa MIJ, Karvonen MK, Pesonen U, Koulu M. 1999. Neuropeptidi Y ja veren kolesterolipitoisuus DUODECIM 115: 241-242. 1999

Valve R, Sivenius K, Miettinen R, Pihlajamäki J, Rissanen A, Deeb SS, Auwerx J, Uusitupa M, Laakso M. 1999. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 84 10: 3708-3712. 1999

Vidgren HM, Ågren JJ, Valve RS, Karhunen LJ, Rissanen AM, Uusitupa MIJ. 1999. The effect of orlistat on the fatty acid composition of serum lipid fractions in obese subjects. CLINICAL PHARMACOLOGY AND THERAPEUTICS 66: 315-322. 1999

Leinonen K, Liukkonen K, Poutanen K, Uusitupa M, Mykkänen H. 1999. Rye bread decreases postprandial insulin response but does not alter glucose response in healthy Finnish subjects. EUROPEAN JOURNAL OF CLINICAL NUTRITION 53: 262-267. 1999

Männistö S, Pietinen P, Virtanen M, Kataja V, Uusitupa M. 1999. Diet and the risk of breast cancer in a case-control study: does the threat of disease have an influence on recall bias? JOURNAL OF CLINICAL EPIDEMIOLOGY 52 5: 429-439. 1999

Laaksonen DE, Atalay M, Niskanen L, Uusitupa M, Hänninen O, Sen CK. 1999. Blood glutathione homeostasis as a determinant of resting and exercise-induced oxidative stress in young men. REDOX REPORT (EDINBURGH) 4 1/2: 53 - 59. 1999

Hallikainen MA, Sarkkinen ES, Uusitupa MIJ. 1999. Effects of low-fat stanol ester enriched margarines on concentrations of serum carotenoids in subjects with elevated serum cholesterol concentrations. EUROPEAN JOURNAL OF CLINICAL NUTRITION 53: 966-969. 1999

Korhonen MH, Litmanen H, Rauramaa R, Väisänen SB, Niskanen L, Uusitupa MIJ. 1999. Adherence to the salt restriction diet among people with mildly elevated blood pressure. EUROPEAN JOURNAL OF CLINICAL NUTRITION 53: 880-885. 1999

Eriksson J, Valle T, Lindström J, Haffner S, Louheranta A, Uusitupa M, Tuomilehto J, on behalf of the DPS-study group. 1999. Leptin concentrations and their relation to body fat distribution and weight loss - a prospective study in individuals with impaired glucose tolerance HORMONE AND METABOLIC RESEARCH 31: 616-619. 1999

Erkkilä AT, Sarkkinen ES, Lehto S, Pyörälä K, Uusitupa MIJ. 1999. Diet in relation to socioeconomic status in patients with coronary heart disease. EUROPEAN JOURNAL OF CLINICAL NUTRITION 52: 662-668. 1999

Erkkilä AT, Sarkkinen ES, Lehto S, Pyörälä K, Uusitupa MIJ. 1999. Dietary associates of serum total, LDL, and HDL cholesterol and triglycerides in patients with coronary heart disease PREVENTIVE MEDICINE 28: 558-565. 1999

Fogelholm M, Uusitupa M. 1999. Kehon koostumuksen arviointi: Aro A, Mutanen M, Uusitupa M, Ravitsemustiede.Duodecim. 273-279. 1999

Fogelholm M, Uusitupa M. 1999. Liikunta, energiankulutus ja ravitsemus: Vuori I, Taimela S, Liikuntalääketiede. 2., uud. p..Duodecim. 73-82. 1999

Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Lauhkonen M, Lehto P, Louheranta A, Mannelin M, Martikkala V, Rastas M, Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J. 1999. Prevention of type II diabetes in subjects with impaired glucose tolerance:the Diabetes Prevention Study (DPS) in Finland: study design and 1-year interim report on the feasibility of the lifestyle intervention programme. DIABETOLOGIA 42: 793-801. 1999

Hallikainen MA, Uusitupa MIJ. 1999. Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as a part of a low-fat diet in hypercholesterolemic subjects. AMERICAN JOURNAL OF CLINICAL NUTRITION 69: 403-410. 1999

Karhunen LJ, Lappalainen RI, Vanninen EJ, Kuikka JT, Uusitupa MIJ. 1999. Serum leptin and regional cerebral blood flow during exposure to food in obese and normal-weight women NEUROENDOCRINOLOGY 69: 154-159. 1999

Kemppainen T, Kröger H, Janatuinen E, Arnala I, Kosma V-M, Pikkarainen P, Julkunen R, Jurvelin J, Alhava E, Uusitupa M. 1999. Osteoporosis in adult patients with celiac disease. BONE 24 3: 249-255. 1999

Kemppainen T, Kröger H, Janatuinen E, Arnala I, Lamberg-Allardt C, Kärkkäinen M, Kosma V-M, Julkunen R, Jurvelin J, Alhava E, Uusitupa M. 1999. Bone recovery after a gluten-free diet: a 5-year follow-up study. BONE 25 3: 355-360. 1999

Kemppainen TA, Uusitupa MI, Kosma V-M, Julkunen RJ. 1999. Reply to S Jameson (to Villous atrophy and nutritional status in celiac disease) AMERICAN JOURNAL OF CLINICAL NUTRITION 69 3: 574. 1999

Keskikuru R, Kataja V, Kosma V-M, Eskelinen M, Uusitupa M, Johansson R, Risteli L, Risteli J, Jukkola A. 1999. Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer. ANTICANCER RESEARCH 19: 4481-4484. 1999

Koikkalainen M, Mykkänen H, Erkkilä A, Julkunen J, Saarinen T, Pyörälä K, Uusitupa M, Lappalainen R. 1999. Difficulties in changing the diet in relation to dietary fat intake among patients with coronary heart disease EUROPEAN JOURNAL OF CLINICAL NUTRITION 53: 120-125. 1999

Heinonen P, Koulu M, Pesonen U, Karvonen MK, Rissanen A, Laakso M, Valve R, Uusitupa M, Scheinin M. 1999. Identification of a three-amino acid deletion in the alfa2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 84: 2429-2433. 1999

Uusitupa M. 1998. Perimä ja lihavuus. Teoksessa: Fogelholm M, Mustajoki P, Rissanen A, Uusitupa M (toim.), Lihavuus: ongelma ja hoito. 2. uud. p..Duodecim. ss. 60-69. 1998

Uusitupa M. 1998. Aineenvaihdunnan ja ravitsemuksen häiriöt: diabetes: Koskenvuo K, Vertio H, Sairauksien ehkäisy.Duodecim. 177-184. 1998

Uusitupa M. 1998. Aineenvaihdunnan ja ravitsemuksen häiriöt: lihavuus: Koskenvuo K, Vertio H, Sairauksien ehkäisy.Duodecim. 171-177. 1998

Uusitupa M. 1998. Hypo-cholesterolaemic effects of dietary fibre in relation to genetic factors: Guillon E, Amado R et al., Functional Properties of Non-Digestible Carbohydrates. European Air Concerted Action AIR3CT94-2203.European Commission. 97-100. 1998

Uusitupa M. 1998. Kost som prevention mot fetma: Andersen T, Rissanen A, Rössner S (red.), Fetma/fedme - en nordisk lärobok.Studentlitteratur. 325-330. 1998

Uusitupa M. 1998. Lihavuus ja terveys: Fogelholm M, Mustajoki P, Rissanen A, Uusitupa M, Lihavuus : ongelma ja hoito. 2. uud. p..Duodecim. 19-28. 1998

Uusitupa M. 1998. Mäkihyppääjien ravitsemustila - kevyempänä lentää kauemmaksi. SUOMEN LÄÄKÄRILEHTI 53 8: 836-837. 1998

Vauhkonen I, Niskanen L, Haffner S, Kainulainen S, Uusitupa M, Laakso M. 1998. Insulin resistant phenotype is associated with high serum leptin levels in offspring of patients with non-insulin-dependent diabetes mellitus. EUROPEAN JOURNAL OF ENDOCRINOLOGY 139: 598-604. 1998

Uusitupa MIJ, Karvonen MK, Pesonen U, Koulu M. 1998. Neuropeptide Y: a novel link between the neuroendocrine system and cholesterol metabolism ANNALS OF MEDICINE (HELSINKI) 30: 508-510. 1998

Uusitupa MIJ, Sarkkinen ES. 1998. Risk factors of cardiovascular disease in the elderly. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 8 5: 341-348. 1998

Valve R, Heikkinen S, Rissanen A, Laakso M, Uusitupa M. 1998. Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on basal metabolic rate in obese Finns. DIABETOLOGIA 41: 357-361. 1998

Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M. 1998. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited: metabolic studies on offspring of diabetic probands JOURNAL OF CLINICAL INVESTIGATION 101 1: 86-96. 1998

Vidgren HM, Louheranta AM, Ågren JJ, Schwab US, Uusitupa MIJ. 1998. Divergent incorporation of dietary trans fatty acids in different serum lipid fractions. LIPIDS 33 10: 955-962. 1998

Ågren JJ, Valve R, Vidgren H, Laakso M, Uusitupa M. 1998. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. ARTERIOSCLEROSIS, THROMBOSIS AND VASCULAR BIOLOGY 18: 1606-1610. 1998

Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HPF, Krempf M, for the European Multicentre Orlistat Group, Uusitupa M. 1998. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. LANCET 352: 167-173. 1998

Uusitupa M, Van Gaal L. 1998. Early intervention in obesity: implications for impaired glucose tolerance and type II diabetes. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. SUPPLEMENT 28 2: 1. 1998

Sarkkinen ES, Uusitupa MIJ, Gylling H, Miettinen TA. 1998. Fat-modified diets influence serum concentrations of cholesterol precursors and plant sterols in hypercholesterolemic subjects. METABOLISM: CLINICAL AND EXPERIMENTAL 47 6: 744-750. 1998

Schwab US, Sarkkinen ES, Lichtenstein AH, Li Z, Ordovas JM, Schaefer EJ, Uusitupa MIJ. 1998. The effect of quality and amount of dietary fat on the susceptibility of low density lipoprotein to oxidation in subjects with impaired glucose tolerance. EUROPEAN JOURNAL OF CLINICAL NUTRITION 52: 452-458. 1998

Kemppainen TA, Kosma V-M, Janatuinen EK, Julkunen RJ, Pikkarainen PH, Uusitupa MI. 1998. Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet - association with the grade of mucosal villous atrophy1-3 AMERICAN JOURNAL OF CLINICAL NUTRITION 67: 482-487. 1998

Collin H-L, Uusitupa M, Niskanen L, Koivisto A-M, Markkanen H, Meurman JH. 1998. Caries in patients with non-insulin-dependent diabetes mellitus. ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY, ORAL RADIOLOGY AND ENDODONTICS 85 6: 680-685. 1998

Erkkilä AT, Sarkkinen ES, Koukkunen H, Kemppainen A, Lehto S, Pyörälä K, Uusitupa MIJ. 1998. Concordance of diet with the recommended cholesterol lowering diet in patients with coronary heart disease EUROPEAN JOURNAL OF CLINICAL NUTRITION 52: 279-285. 1998

Kansanen M, Vanninen E, Tuunainen A, Pesonen P, Tuononen V, Hartikainen J, Mussalo H, Uusitupa M. 1998. The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING 18 4: 377-385. 1998

Karhunen LJ, Lappalainen RI, Haffner SM, Valve RH, Tuorila H, Miettinen H, Uusitupa MIJ. 1998. Serum leptin, food intake and preferences for sugar and fat in obese women INTERNATIONAL JOURNAL OF OBESITY 1998 22: 819-821. 1998

Karvonen MK, Pesonen U, Heinonen P, Laakso M, Rissanen A, Naukkarinen H, Valve R, Uusitupa MIJ, Koulu M. 1998. Identification of new sequence variants in the leptin gene. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 83 9: 3239-3242. 1998

Karvonen MK, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A, Dekker JM, ¿T Hart LM, Valve R, Uusitupa MIJ. 1998. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. NATURE MEDICINE 4 12: 1434-1437. 1998

Collin H-L, Uusitupa M, Niskanen L, Kontturi-Närhi V, Markkanen H, Koivisto A-M, Meurman JH. 1998. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. JOURNAL OF PERIODONTOLOGY 69: 962-966. 1998

Koukkunen H, Kemppainen A, Lehto S, Erkkilä A, Sarkkinen E, Uusitupa M, Pyörälä K. 1998. Sepelvaltimotaudin sekundaariprevention toteutuminen KYS:ssa hoidetuilla potilailla: EUROASPIRE-tutkimuksen tuloksia SUOMEN LÄÄKÄRILEHTI 53 17: 2029-2041. 1998

Meurman JH, Collin H-L, Niskanen L, Töyry J, Alakuijala P, Keinänen S, Uusitupa M. 1998. Saliva in non-insulin-dependent diabetic patients and control subjects: the role of the autonomic nervous system. ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY, ORAL RADIOLOGY AND ENDODONTICS 86: 69-76. 1998

Mustajoki P, Rissanen A, Uusitupa M. 1998. Lihavan potilaan tutkiminen ja hoitomuodon valinta: Fogelholm M, Mustajoki P, Rissanen A, Uusitupa M, Lihavuus: ongelma ja hoito. 2. uud. p..Duodecim. 103-107. 1998

Niskanen L, Turpeinen A, Penttilä I, Uusitupa MIJ. 1998. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. DIABETES CARE 21 11: 1861-1869. 1998

Rankinen T, Lyytikäinen S, Vanninen E, Penttilä I, Rauramaa R, Uusitupa M. 1998. Nutritional status of the Finnish elite ski jumpers. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE 30 11: 1592-1597. 1998

Rissanen A, Uusitupa M. 1998. Lihavuuden syyt: Fogelholm M, Mustajoki P, Rissanen A, Uusitupa M, Lihavuus: ongelma ja hoito. 2. uud. p..Duodecim. 89-91. 1998

Sarkkinen E, Korhonen M, Erkkilä A, Ebeling T, Uusitupa M. 1998. Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol 1-3. AMERICAN JOURNAL OF CLINICAL NUTRITION 68: 1215-1222. 1998

Louheranta AM, Turpeinen AK, Schwab US, Vidgren HM, Parviainen MT, Uusitupa MIJ. 1998. A high-stearic acid diet does not impair glucose tolerance and insulin sensitivity in healthy women. METABOLISM: CLINICAL AND EXPERIMENTAL 47 5: 529-534. 1998

Töyry JP, Niskanen LK, Mäntysaari MJ, Länsimies EA, Haffner SM, Miettinen HJJ, Uusitupa MIJ. 1997. Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction? Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects CIRCULATION 96: 1185-1191. 1997

Sipiläinen R, Uusitupa M, Heikkinen S, Rissanen A, Laakso M. 1997. Polymorphism of the Beta3-adrenergic receptor gene affects basal metabolic rate in obese Finns DIABETES (NY) 46: 77-80. 1997

Sipiläinen R, Uusitupa M, Heikkinen S, Rissanen A, Laakso M. 1997. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 82: 2629-2632. 1997

Suomen Gastroenterologiayhdistys Ry, Uusitupa M, Julkunen R. 1997. Keliakian hoitosuositus. DUODECIM 113 1: [6]. 1997

Turpeinen AK, Haffner SM, Louheranta AM, Niskanen LK, Miettinen H, Uusitupa MIJ. 1997. Serum leptin in subjects with impaired glucose tolerance in relation to insulin sensitivity and first-phase insulin responce. INTERNATIONAL JOURNAL OF OBESITY 21: 284-287. 1997

Turpeinen AK, Kuikka JT, Vanninen E, Uusitupa MIJ. 1997. Abnormal myocardial kinetics of 123I-heptadecanoic acid in subjects with impaired glucose tolerance DIABETOLOGIA 40: 541-549. 1997

Uusitupa MIJ, Miettinen TA, Sarkkinen ES, Ruuskanen E, Kervinen K, Kesäniemi YA. 1997. Lathosterol and other non-cholesterol sterols during treatment of hypercholesteroleamia with beta-glucan-rich oat bran. EUROPEAN JOURNAL OF CLINICAL NUTRITION 51: 607-611. 1997

Töyry JP, Partanen JVS, Niskanen LK, Länsimies EA, Uusitupa MIJ. 1997. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. DIABETOLOGIA 40: 953-958. 1997

Uusitupa M, Aro A, Mykkänen H, Rissanen A. 1997. Ravinto,terveytemme perusta nyt ja tulevaisuudessa. SUOMEN LÄÄKÄRILEHTI 52 17: 2181-2186. 1997

Uusitupa M. 1997. Lihavuus ja terveys: Fogelholm M, Mustajoki P, Rissanen A, Uusitupa M, Lihavuus.Ongelma ja hoito.Duodecim. 15-25. 1997

Uusitupa M. 1997. Miten aikuisiän diabeteksen hoitotuloksia voitaisiin parantaa SUOMEN LÄÄKÄRILEHTI 52 5: 403-405. 1997

Vauhkonen I, Niskanen L, Ryynänen M, Voutilainen R, Partanen J, Töyry J, Mercuri M, Rauramaa R, Uusitupa M. 1997. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects. DIABETIC MEDICINE 14: 748-756. 1997

Vidgren HM, Ågren JJ, Schwab U, Rissanen T, Hänninen O, Uusitupa MIJ. 1997. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. LIPIDS 32 7: 697-705. 1997

Schwab US, Karhapää P, Sarkkinen ES, Salminen I, Laakso M, Uusitupa MIJ. 1997. Metabolic effects of diets rich in saturated and omega-6 polyunsatured fatty acids in healthy young females. DIABETES, NUTRITION & METABOLISM 10: 35-38. 1997

Schwab US, Niskanen L, Uusitupa MIJ. 1997. Palmitic and stearic acid enriched diets have similar effects on glucose metabolism in healthy young females. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 7: 315-319. 1997

Vidgren HM, Sipiläinen RH, Heikkinen S, Laakso M, Uusitupa MIJ. 1997. Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 27: 405-408. 1997

Satellite Symposium on Nutrition, Obesity and Diabetes. Uusitupa M. 1997 1997

Koivisto V, Groop PH, Huttunen N-P, Kivekäs J, Pasternack A, Uusitupa M, Viikari J. 1997. Diabetesnefropati - screening, uppföljning och behandling. NORDISK MEDICIN 112: 154-162. 1997

Rissanen P, Hämäläinen P, Vanninen E, Tenhunen-Eskelinen M, Uusitupa M. 1997. Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy X-ray absorptiometry in obese middle-aged women. INTERNATIONAL JOURNAL OF OBESITY 21 5: 367-371. 1997

Janatuinen E, Julkunen R, Uusitupa M. 1997. Kaura ja keliakia. DUODECIM 113 4: 269-270. 1997

Karhunen L, Franssila-Kallunki A, Rissanen A, Kervinen K, Kesäniemi YA, Uusitupa M. 1997. Determinants of resting energy expenditure in obese non-diabetic caucasian women INTERNATIONAL JOURNAL OF OBESITY 21: 197-202. 1997

Karhunen L, Haffner S, Lappalainen R, Turpeinen A, Miettinen H, Uusitupa M. 1997. Serum leptin and short-term regulation of eating in obese women. CLINICAL SCIENCE (LONDON) 92: 573-578. 1997

Karhunen LJ, Lappalainen RI, Tammela L, Turpeinen AK, Uusitupa MIJ. 1997. Subjective and physiological cephalic phase responses to food in obese binge-eating women. INTERNATIONAL JOURNAL OF EATING DISORDERS 21: 321-328. 1997

Karhunen LJ, Lappalainen RI, Vanninen EJ, Kuikka JT, Uusitupa MIJ. 1997. Regional cerebral blood flow during food exposure in obese and normal-weight womem. BRAIN 120: 1675-1684. 1997

Atalay M, Laaksonen DE, Niskanen L, Uusitupa M, Hänninen O, Sen CK. 1997. Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress. ACTA PHYSIOLOGICA (OXFORD) 161: 195-201. 1997

Mustajoki P, Rissanen A, Uusitupa M. 1997. Lihavan potilaan tutkiminen ja hoitomuodon valinta: Fogelholm M, Mustajoki P, Rissanen A, Uusitupa M, Lihavuus. Ongelma ja hoito.Duodecim. 88-92. 1997

Niskanen L, Haffner S, Karhunen LJ, Turpeinen AK, Miettinen H, Uusitupa MIJ. 1997. Serum leptin in relation to resting energy expenditure and fuel metabolism in obese subjects. INTERNATIONAL JOURNAL OF OBESITY 21: 309-313. 1997

Niskanen L, Schwab US, Sarkkinen ES, Krusius T, Vahtera E, Uusitupa MIJ. 1997. Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance. METABOLISM: CLINICAL AND EXPERIMENTAL 46: 666-672. 1997

Niskanen LK, Haffner S, Karhunen LJ, Turpeinen AK, Miettinen H, Uusitupa MIJ. 1997. Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss. EUROPEAN JOURNAL OF ENDOCRINOLOGY 137: 61-67. 1997

Pirinen E, Uusitupa M, Tuononen V, Poikolainen E, Pääkkönen M, Alhava E. 1997. Mahapantaleikkaus - sairaalloisen lihavuuden uusi hoitomuoto. DUODECIM 113: 1471-1475. 1997

Rissanen A, Uusitupa M. 1997. Lihavuuden syyt: Fogelholm M, Mustajoki P, Rissanen A, Uusitupa M, Lihavuus. Ongelma ja hoito.Duodecim. 56-67. 1997

Mustonen J, Uusitupa M, Mäntysaari M, Länsimies E, Pyörälä K, Laakso M. 1997. Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease. JOURNAL OF INTERNAL MEDICINE 241: 227-235. 1997

Uusitupa M. 1996. Diabetestutkimuksen näkymiä. DIABETES (LÄÄKÄRILIITE, JOULUKUU) 48 12: 3-5. 1996

Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MIJ. 1996. Demonstration of regional sympathetic denervation of the heart in diabetes. DIABETES CARE 19 10: 1083-1090. 1996

Töyry JP, Niskanen LK, Länsimies EA, Partanen KPL, Uusitupa MIJ. 1996. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. STROKE 27: 1316-1318. 1996

Uusitupa M, Korhonen M, Litmanen H, Niskanen L, Väisänen S, Rauramaa R. 1996. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure. JOURNAL OF HUMAN HYPERTENSION 10: 319-326. 1996

Uusitupa M. 1996. Aikuistyypin diabeteksen ehkäisylle on vankat perusteet. DIABETES (LÄÄKÄRILIITE, HELMIKUU) 48 1-2: 3. 1996

Uusitupa M. 1996. Aikuistyypin diabeteksen hoidon periaatteet - repetitio mater studiorum est. SUOMEN LÄÄKÄRILEHTI 51 10: 1065-1067. 1996

Uusitupa MIJ, Karhunen L, Rissanen A, Franssila-Kallunki A, Niskanen L, Kervinen K, Kesäniemi YA. 1996. Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women 1-3. AMERICAN JOURNAL OF CLINICAL NUTRITION 64: 131-136. 1996

Uusitupa M. 1996. Lääkkeettömät keinot aikuistyypin diabeteksen ehkäisyssä. DIABETES (LÄÄKÄRILIITE, HELMIKUU) 48 1-2: 13-16. 1996

Uusitupa M. 1996. Metabolic control and macrovascular disease: Alberti P,Zimmet RA,DeFronzo, Keen H, International Textbook of Diabetes Mellitus, Second Edition.K.G.M.M. 1-17. 1996

Uusitupa M. 1996. Ravitsemusneuvonnasta lisäpotkua diabeetikon hoitoon. DIABETES (LÄÄKÄRILIITE, HUHTIKUU) 48 4: 3. 1996

Uusitupa MIJ, Niskanen L, Luoma J, Vilja P, Mercuri M, Rauramaa R, Ylä-Herttuala S. 1996. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. ARTERIOSCLEROSIS, THROMBOSIS AND VASCULAR BIOLOGY 16: 1236-1242. 1996

Uusitupa MIJ. 1996. Early lifestyle intervention in patients with non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Annals of Medicine 28: 445-449. 1996

Vanninen E, Uusitupa MIJ, Länsimies E. 1996. Ventricular repolarization is correlated with metabolic control in newly diagnosed type 2 diabetes. CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING 16: 449-461. 1996

Suomen Sisätautilääkärien yhdistyksen, Suomen Kardiologisen seuran, Suomen Verenpaineyhdistyksen, Kunnallislääkärit-yhdistyksen, Suomen Teollisuuslääketieteen yhdistyksen ja Suomen Sydäntautiliiton työryhmä, Pyörälä K, Uusitupa M. 1996. Sepelvaltimotaudin ehkäisy käytännön lääkärintyössä. SUOMEN LÄÄKÄRILEHTI 51 8: 783-802. 1996

Turpeinen AK, Kuikka JT, Vanninen E, Vainio P, Vanninen R, Litmanen H, Koivisto VA, Bergström K, Uusitupa MIJ. 1996. Athletic heart: a metabolic, anatomical, and functional study. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE 28 1: 33-40. 1996

Zhu Z, Parviainen M, Männistö S, Pietinen P, Eskelinen M, Syrjänen K, Uusitupa M. 1996. Vitamin E concentration in breast adipose tissue of breast cancer patients (Kuopio, Finland). CANCER CAUSES AND CONTROL 7: 591-595. 1996

Suomen Diabetesliiton nefropatiatyöryhmä, Uusitupa M. 1996. Diabeettinen nefropatia-seulonta, seuranta ja hoito 1996. SUOMEN LÄÄKÄRILEHTI 51 25: 2479-2489. 1996

Laaksonen DE, Atalay M, Niskanen L, Uusitupa M, Hänninen O, Sen CK. 1996. Increased resting and excercise-indused oxidative stress in young IDDM men. DIABETES CARE 19 6: 569-574. 1996

Schwab US, Maliranta HM, Sarkkinen ES, Savolainen MJ, Kesäniemi YA, Uusitupa MIJ. 1996. Different effects of palmitic and stearic acid-enriched diets on serum lipids and lipoproteins and plasma cholesterol ester transfer protein activity in healthy young women. METABOLISM: CLINICAL AND EXPERIMENTAL 45 2: 143-149. 1996

Alakärppä S, Nuutinen O, Lampainen E, Uusitupa M. 1996. Hemodialyysipotilaiden ravitsemustila. DUODECIM 112: 986-993. 1996

Janatuinen EK, Julkunen RJK, Uusitupa MI. 1996. The authors reply (to Oats in celiac disease). NEW ENGLAND JOURNAL OF MEDICINE 334 13: 866. 1996

Karhunen LJ, Lappalainen RI, Niskanen LK, Turpeinen AK, Uusitupa MIJ. 1996. Determinants of the cephalic-phase insulin response in obese nondiabetic subjects METABOLISM: CLINICAL AND EXPERIMENTAL 45 2: 168-173. 1996

Kesäniemi YA, Savolainen MJ, Uusitupa M, Sarkkinen E, Rantala M, Kervinen K. 1996. Apolipoprotein E phenotypes and response to dietary fat and cholesterol. Teoksessa: Bray GA, Ryan DH (toim.), Nutrition, Genetics, and Heart Disease.Louisiana State University Press. Pennington Center Nutrition Series. ss. 379-387. 1996

Kumar S, Boulton AJM, Beck-Nielsen H, Berthezene F, Muggeo M, Persson B, Spinas GA, Donoghue S, Lettis S, Stewart-Long P, for the Troglitazone study group, Uusitupa M. 1996. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients DIABETOLOGIA 39: 701-709. 1996

Honkanen R, Pulkkinen P, Järvinen R, Kröger H, Lindstedt K, Tuppurainen M, Uusitupa M. 1996. Does lactose intolerance predispose to low bone density? A population-based study of perimenopausal Finnish women BONE 19 1: 23-28. 1996

Männistö S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M. 1996. Body-size indicators and risk of breast cancer according to menopause and estrogen-reseptor status. INTERNATIONAL JOURNAL OF CANCER 68: 8-13. 1996

Niskanen L, Rauramaa R, Miettinen H, Haffner SM, Mercuri M, Uusitupa M. 1996. Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. STROKE 27: 1986-1992. 1996

Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Paljärvi L, Laakso M. 1996. The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects INTERNATIONAL JOURNAL OF OBESITY 20: 154-160. 1996

Rissanen PM, Laakkonen EI, Suntioinen S, Penttilä IM, Uusitupa MI. 1996. The nutritional status of Finnish home-living elderly people and the relationship between energy intake and chronic diseases. AGE AND AGEING 25: 133-138. 1996

Sarkkinen E, Uusitupa M. 1996. Onko kalarasvalla ja n-3-sarjan monityydyttymättömillä rasvahapoilla merkitystä sairauksien ehkäisyssä ja hoidossa?. DUODECIM 112: 1755-1763. 1996

Sarkkinen E, Schwab U, Niskanen L, Hannuksela M, Savolainen M, Kervinen K, Kesäniemi A, Uusitupa MIJ. 1996. The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance. EUROPEAN JOURNAL OF CLINICAL NUTRITION 50: 592-598. 1996

Mäntysaari M, Kuikka J, Mustonen J, Tahvanainen K, Vanninen E, Länsimies E, Uusitupa M. 1996. Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus. CLINICAL AUTONOMIC RESEARCH 6: 163-169. 1996

Uusitupa M. 1995. Kauraa keliaakikoille. SUOMEN LÄÄKÄRILEHTI 50: 3476-3477. 1995

Uusitupa M, Sarkkinen E. 1995. Mitä rasvaa leivän päälle?. DUODECIM 111: 1281-1282. 1995

Uusitupa M. 1995. Aikuistyypin diabeteksen hoitosuositus uusittu. SUOMEN LÄÄKÄRILEHTI 50: 167-169. 1995

Uusitupa M. 1995. Energiestoffwechsel bei typ-II-(non-insulindependent) Diabetes mellitus und Adipositas. DIABETES UND STOFFWECHSEL 4: 263-264. 1995

Viinamäki H, Niskanen L, Uusitupa M. 1995. Mental well-being in people with non-insulin-dependent diabetes. ACTA PSYCHIATRICA SCANDINAVICA 92: 392-397. 1995

Uusitupa M. 1995. Metabolinen oireyhtymä. KÄYTÄNNÖN LÄÄKÄRI 4: 147-151. 1995

Uusitupa M. 1995. Miten ehkäistä diabeetikon koronaaritautia?. DIABETES JA LÄÄKÄRI: 7,11. 1995

Uusitupa MIJ, Niskanen LK. 1995. Hyperglycemia and cardiovascular risk in NIDDM. DIABETES CARE 18: 884-885. 1995

Zhu ZR, Parviainen M, Männistö S, Pietinen P, Eskelinen M, Syrjänen K, Uusitupa M. 1995. Vitamin A concentration in breast adipose tissue of breast cancer patients. ANTICANCER RESEARCH 15: 1593-1596. 1995

Zhu ZR, Ågren J, Männistö S, Pietinen P, Eskelinen M, Syrjänen K, Uusitupa M. 1995. Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with bening breast disease. NUTRITION AND CANCER 24: 151-160. 1995

Schwab US, Niskanen LK, Maliranta HM, Savolainen MJ, Kesäniemi YA, Uusitupa MIJ. 1995. Lauric and palmitic acid-enriched diets have minimal impact on serum lipid and lipoprotein concentrations and glucose metabolism in healthy young women. JOURNAL OF NUTRITION 125: 466-473. 1995

Slama G, Lean M, Mann J, Toeller M, Chantelau E, Van Gaal L, Heine R, Karamantos B, Karlstrom B, De Leeuw I, Librenti M, Riccardi G, Rivellese A, Teuscher A, Uusitupa M, Vessby B. 1995. Recommendations for the nutritional management of patients with diabetes mellitus DIABETES, NUTRITION & METABOLISM 8: 1-4. 1995

Uusitupa M, Nuutinen L. 1995. Ravitsemustilan arviointi käytännön potilastyössä SUOMEN LÄÄKÄRILEHTI 50: 888-889. 1995

Rankinen T, Fogelholm M, Kujala U, Rauramaa R, Uusitupa M. 1995. Dietary intake and nutritional status of athletic and nonathletic children in early puberty. INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM 5: 136-150. 1995

Mykkänen H, Sipiläinen R, Uusitupa M. 1995. The role of rye in Finnish diet. Teoksessa: Poutanen K, Autio K (toim.), International Rye Symposium: Technology and Products, VTT Symposium 161.Technical Research Centre of Finland. ss. 77-82. 1995

Pesonen PHM, Vanninen E, Tuononen V, Tuunainen A, Kansanen M, Hartikainen J, Mussalo H, Uusitupa M. 1995. Uniapneapotilaiden laihdutus ja autonomisen hermoston toiminta DUODECIM 111: 1136-1140. 1995

Fogelholm M, Uusitupa M. 1995. Liikunta, energiankulutus ja ravitsemus. Teoksessa: Vuori I, Taimela S (toim.), Liikuntalääketiede.Duodecim. ss. 69-79. 1995

Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma V-M, Järvinen RMK, Uusitupa MIJ, Julkunen RJK. 1995. A comparison of diets with and without oats in adults with celiac disease. NEW ENGLAND JOURNAL OF MEDICINE 333: 1033-1037. 1995

Kemppainen T, Uusitupa M, Janatuinen E, Järvinen R, Julkunen R, Pikkarainen P. 1995. Intakes of nutrients and nutritional status in coeliac patients. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 30: 575-579. 1995

Helkala E-L, Niskanen L, Viinamäki H, Partanen J, Uusitupa M. 1995. Short-term and long-term memory in elderly patients with NIDDM. DIABETES CARE 18: 681-685. 1995

Mäntysaari M, Kuikka J, Hartikainen J, Mustonen J, Mussalo H, Tahvanainen K, Länsimies E, Uusitupa M, Pyörälä K. 1995. Myocardial sympathetic nervous dysfunction detected with iodine-123-MIBG is associated with low heart rate variability after myocardial infarction. JOURNAL OF NUCLEAR MEDICINE 36 6: 956-961. 1995

Niskanen LK, Salonen JT, Nyyssönen K, Uusitupa MIJ. 1995. Plasma lipid peroxidation and hyperglycaemia: a connection trough hyperinsulinaemia?. DIABETIC MEDICINE 12: 802-808. 1995

Niskanen LK, Tuomi TM, Karjalainen J, Groop LC, Uusitupa MIJ. 1995. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. DIABETES CARE 18 12: 1557-1565. 1995

Nissinen A, Enlund H, Korhonen M, Uusitupa M, Niskanen L, Lempiäinen-Kuosa P, Tuomilehto J. 1995. Hyperkolesterolemian hoito lääkäreiden ilmoituksen mukaan vuosina 1985 ja 1992. SUOMEN LÄÄKÄRILEHTI 50 17: 2003-2006. 1995

Nuutinen L, Uusitupa M. 1995. Tehostettu ravitsemushoito. SUOMEN LÄÄKÄRILEHTI 50: 1991-1993. 1995

Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. 1995. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. NEW ENGLAND JOURNAL OF MEDICINE 333: 89-94. 1995

Uusitupa M, Niskanen L. 1994. Veren suurentunut glukoosipitoisuus lisää aikuistyypin diabeetikon valtimotautiriskiä. DUODECIM 110 12: 1119-1120. 1994

Uusitupa MIJ. 1994. Fructose in the diabetic diet. AMERICAN JOURNAL OF CLINICAL NUTRITION 59: 753S-757S. 1994

Uusitupa MIJ, Sarkkinen ES, Torpström J, Pietinen P, Aro A. 1994. Long-term effects of four fat-modified diets on blood pressure JOURNAL OF HUMAN HYPERTENSION 8: 209-218. 1994

Uusitupa M. 1994. Tehostettu ruokavalio-ohjaus voi motivoida parempaan hoitotulokseen DIABETES (LÄÄKÄRILIITE, SYYSKUU) 46 9: 17-25. 1994

Uusitupa M. 1994. Do genetic markers modify serum cholesterol lowering effects of dietary fiber?: Lairon D, Mechanisms of action of dietary fibre on lipid and cholesterol metabolism. Proceedings of a Workshop Held.Commission of the European Communities. 159-161. 1994

Uusitupa M. 1994. Cholesterol synthesis in humans. Teoksessa: Lairon D (toim.), Mechanisms of action of dietary fibre on lipid and cholesterol metabolism. Proceedings of a Workshop Held.Commission of the European Communities. ss. 71-75. 1994

Uusitupa M. 1994. Aikuistyypin diabetes: Hyperglykemia ja elinkomplikaatiot. DIABETES (LÄÄKÄRILIITE, HELMIKUU) 2: 10-17. 1994

Uusitupa M, Schwab U, Mäkimattila S, Karhapää P, Sarkkinen E, Maliranta H, Ågren J, Penttilä I. 1994. Effects of two high-fat diets with different fatty acid compositions on glucose and lipid metabolism in healthy young women. AMERICAN JOURNAL OF CLINICAL NUTRITION 59: 1310-1316. 1994

Uusitupa M, Sarkkinen E, Kervinen K, Kesäniemi YA. 1994. Apolipoprotein E phenotype and blood pressure. LANCET 343 1: 57. 1994

Niskanen L, Karjalainen J, Siitonen O, Uusitupa M. 1994. Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis. JOURNAL OF INTERNAL MEDICINE 236: 263-270. 1994

Sarkkinen ES, Ågren JJ, Ahola I, Ovaskainen M-L, Uusitupa MIJ. 1994. Fatty acid composition of serum cholesterol esters, and erythrocyte and platelet membranes as indicators of long-term adherence to fat-modified diets. AMERICAN JOURNAL OF CLINICAL NUTRITION 59: 364-70. 1994

Sarkkinen ES, Uusitupa MIJ, Pietinen P, Aro A, Ahola I, Penttilä I, Kervinen K, Kesäniemi YA. 1994. Long-term effects of three fat-modified diets in hypercholesterolemic subject. ATHEROSCLEROSIS 105: 9-23. 1994

Sarkkinen ES, Uusitupa M. 1994. Stability and magnitude of serum low-density lipoprotein response to a 6-month dietary intervention. NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES 4: 36-42. 1994

Rankinen T, Rauramaa R, Väisänen S, Penttilä IM, Uusitupa M. 1994. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors. THROMBOSIS AND HAEMOSTASIS 71 2: 180-183. 1994

Nuutinen L, Uusitupa M. 1994. Enteraalinen vai parenteraalinen ravitsemus?. DUODECIM 110 20: 1935-1943. 1994

Niskanen L, Mykkänen L, Uusitupa M, Karonen S-L. 1994. Apoprotein (a) is not a predictor of cardiovascular events in elderly patients with Type 2 (non-insulin-dependent) diabetes. CARDIOVASCULAR RISK FACTORS 4 2: 71-73. 1994

Niskanen L, Enlund H, Jormanainen V, Nissinen A, Uusitupa M. 1994. Therapeutic traditions in type 2 diabetes - are they changing?. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 46: 101-105. 1994

Laitinen J, Uusitupa M, Ahola I, Siitonen O. 1994. Metabolic and dietery determinants of serum lipids in obese patients with recently diagnosed non-insulin-dependent diabetes. Annals of Medicine 26: 119-124. 1994

Laitinen J, Uusitupa M, Ahola I, Laakso M, Siitonen O. 1994. Metabolic and dietary variables associated with glycaemic control in patients with recently diagnosed Type II diabetes mellitus. DIABETES, NUTRITION & METABOLISM 7: 77-87. 1994

Ilmonen M, Heliö T, Ebeling T, Pyörälä K, Uusitupa M, Palotie A, Tikkanen MJ. 1994. Screening for mutations in the exon 26 of the apolipoprotein B gene in hypercholesterolemic Finnish families by the single-strand conformation polymorphism method HUMAN MUTATION 4: 217-223. 1994

Nousiainen U, Mervaala E, Ylinen A, Uusitupa M, Riekkinen P. 1989. Cardiac arrhythmias in the differential diagnosis of epilepsy. JOURNAL OF NEUROLOGY 236: 93-96. 1989

Yhteystiedot

Organisaatio

Sähköposti

Puhelin

Julkaisut